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Membrane targeting of ribosomes synthesizing membrane or secretory proteins is an essential 
process in all cells. One of the most conserved targeting pathways is the signal recognition 
particle (SRP) pathway. In bacteria, the SRP pathway targets ribosomes that are synthesizing 
polytopic membrane proteins to the SecYEG translocon for cotranslational insertion into the 
cytoplasmic membrane. The targeting cycle of SRP starts early during protein synthesis. SRP 
scans translating ribosomes and when it recognizes the N-terminal signal anchor sequence 
(SAS) of a membrane protein it forms a tight complex with the ribosome and the SAS. At this 
stage the complex is targeted to the SecYEG translocon in the membrane by the SRP receptor, 
FtsY. Then the translating ribosome is transferred to the SecYEG in a GTP-controlled manner, 
which initiates membrane insertion. Details of the processes at the membrane are poorly 
understood. This work aimed at studying the interaction between SecYEG and FtsY and before 
and after the translating ribosome has been transferred to the SecYEG translocon.  
In this study we have used monomers of the SecYEG complex embedded into nanodiscs 
(SecYEG(ND)) in combination with fluorescence measurements, in particular fluorescence 
resonance energy transfer (FRET), to determine the affinity of FtsY binding to SecYEG (Kd 0.18 
± 0.02 µM). Using a rapid kinetics approach we verified that FtsY is primarily localized at the 
membrane and that it interacts with SecYEG(ND) via two interaction sites. The binding of 
FtsY to SecYEG(ND) is mediated via both the NG and the A domains. The A domain, 
especially the first 208 amino acids assure the stable binding of FtsY. Further, we have 
demonstrated that the A and NG domain of FtsY are strongly bound to one another keeping 
FtsY in a ‘closed’ conformation when bound to the membrane. The interaction of FtsY with 
SecYEG(ND) induces a rearrangement between the domains and FtsY adopts an ‘open’ 
conformation, which would facilitate the efficient binding of the FtsY-NG domain to the 
homologous domain of SRP. Due to the high affinity of the complex of translating ribosomes 
and SecYEG(ND),  and the increased affinity of ribosome-bound SRP to FtsY the ribosome-
SRP complex is localized properly at the site of the translocon. After the ribosome has been 
transferred to SecYEG and SRP and FtsY have been separated due to GTP hydrolysis, FtsY 
remains associated with the SecYEG complex to take part in another round of targeting. Our 





the translocon before and after ribosomal transfer, but is not essential for GTPase activation. 








2.1 Membrane proteins and targeting mechanisms 
Membrane proteins fulfill various and important functions in the cell, such as ion transport 
and nutrient uptake, cell signaling and cell-to-cell interactions. Membrane proteins account 
for 20-30 % of all open reading frames in the sequenced genomes (Holland, 2010; Pugsley, 
1993). The study of protein translocation through or insertion into membranes started in the 
1950’s with the first description of the organelles in the cell (Siekevitz & Palade, 1958). Major 
insights into how this process works came from studies on the eukaryotic secretory pathway 
by Milstein and colleagues that noted in the early 1970’s that immunoglobulins were made in 
precursor form with a hydrophobic N-terminal sequence that is cleaved in the mature protein 
(Milstein et al, 1972). It was not until few years later that Blobel and Dobberstein provided 
evidence for the signal sequence hypothesis (Blobel & Dobberstein, 1975). Their model, for 
which Blobel received the Nobel Prize in 1999, stated that proteins that are destined for 
translocation are recognized by way of a hydrophobic N-terminal signal sequence that was 
cleaved during the translocation process. At about the same time signal sequences were 
identified in Escherichia coli. Further studies using gene fusion techniques to study protein 
secretion in E.coli provided direct evidence for the presence of signal sequences (Bassford & 
Beckwith, 1979). Furthermore, proteins were identified that comprised the machinery required 
for protein secretion.  
Over the years a remarkable array of protein translocation pathways was found in bacteria 
(Papanikou et al, 2007), but only three systems appear to be present in most bacterial species: 
(a) the Tat pathway, (b) the YidC insertase and (c) the Sec translocon (Figure 2-1). The twin 
arginine translocation (Tat) pathway transports folded proteins across the cytosolic bacterial 
membrane (Berks et al, 2000). Proteins transported by the Tat pathway usually bind to 
cofactors in the cytoplasm, such as redox cofactors, and fold or even oligomerize before 
translocation through the membrane. The Tat substrates have usually in their N terminus a 
‘twin arginine’ (RR) motif. This pathway is present in most bacterial and archaeal species, as 
well as in chloroplast, but is absent in mitochondria (for a comprehensive review, see (Kudva 
et al, 2013)). In contrast the Sec translocon and YidC insertase transport proteins in unfolded 







Figure 2-1 Overview of the major protein targeting pathways in Gram-negative bacteria 
I. In the cell ribosomes associate with various protein factors that are responsible for the proper localization of 
extracytosolic proteins. II. In the early stages of translation the factors scan the ribosomes for specific substrates. 
III.(a) If a signal anchor (SA) sequence is exposed from the ribosome tunnel, SRP associates tighter with the 
ribosome nascent chain complex (RNC). III. (b) Cotranslational targeting of secretory proteins by SecA, has been 
also suggested as an alternative pathway. III (c) Secretory proteins are targeted post-transitionally by SecA/SecB 
to the SecYEG complex. IV. (a) The SRP-RNC complex is tethered to the membrane by the SRP receptor, FtsY. At 
the membrane the RNC is transferred in a GTP-dependent manner to the SecYEG complex or to YidC insertase 
for membrane insertion. IV. (b) SecA facilitates the translocation of secretory proteins through SecYEG by 
utilizing ATP. IV (c) Folded proteins have a double arginine (RR) motif and are translocated via the Tat complex. 
Signal sequenced (SS) of both of Sec and Tat translocated proteins are removed by the signal peptidases (SPase) 





The YidC insertase appears to be the simplest pathway for insertion of proteins into the 
cytosolic membrane (Dalbey et al, 2011). It is present in most bacteria and archaea, and related 
pathways have been described for organelles such as mitochondria (Oxa1) and chloroplasts 
(Alb3) (Funes et al, 2011). YidC can function on its own or in cooperation with the Sec 
translocon during membrane insertion of proteins (Beck et al, 2001; Nagamori et al, 2004). 
The Sec translocon is arguably the best characterized protein transport machinery. It is 
present in all bacteria, archaea, the endoplasmic reticulum of eukaryotic cells, and 
chloroplasts, but not in mitochondria. It has a dual function, as it both transports fully 
synthesized, but unfolded proteins through the membrane in cooperation with the SecA 
translocase and inserts proteins into the membrane in a cotranslational manner. For co-
translational membrane insertion, ribosomes synthesizing membrane proteins are targeted to 
the Sec translocon by the signal recognition particle (SRP) pathway. 
 
2.2 SRP targeting pathway in bacteria  
2.2.1 SecYEG - the protein-conducting channel 
The core of the Sec translocon is the SecYEG heterotrimer. It is an evolutionary conserved 
complex which in Gram-negative bacteria is embedded in the plasma membrane and in 
eukaryotes in the membrane of the endoplasmic reticulum. The first high-resolution structure 
at 3.2 Å was obtained for the SecYEβ translocon of the archaeon Methanococcus jannaschii 
which gave major insights into the structure-function relationship of protein-conducting 
channels of the Sec type in general (Van den Berg et al, 2004). The SecY subunit (Sec61α in 
eukaryotes) comprises ten transmembrane (TM) α-helices. They are organized like a clamp-
shell with one half formed by TM segments 1 – 5 and the second by TM segments 6 – 10. The 
two halves have pseudo-symmetry, in that the second half is essentially the inverted version 
of the first. Exposed to the cytosol are the cytosolic loops C4, C5 and C6, which have an 
important role in docking targeting factors and the ribosome (Figure 2-2, panel A.) (Cheng et 
al, 2005; Chiba et al, 2002; Kuhn et al, 2011).  
The translocation channel of SecY is shaped like an hour-glass with a central constriction 





towards the center of the channel. They are suggested to play a role maintaining the 
permeability barrier during translocation by forming a seal around the peptide passing 
through the channel (Park & Rapoport, 2012). On the periplasmic site the channel is ‘closed’ 
by helix TM2a, which forms the so-called plug domain. It was suggested that during 
translocation the plug is displaced towards the SecE subunit (Tam et al, 2005), although 
crosslinking data (Lycklama & Driessen, 2012) and molecular dynamics simulations (Zhang & 
Miller, 2012) indicate that the plug remains in its original position. However, deletion of the 
TM2a does not result in translocation defects (Maillard et al, 2007), but in fluctuations of the 
channel between ‘opened’ and ‘closed’ state (Saparov et al, 2007). In the plane of the 
membrane SecY can open laterally for the insertion of membrane proteins into the lipid 
bilayer (Bonardi et al, 2010; Higy et al, 2005; Martoglio et al, 1995). For lateral opening of the 
channel and lateral movement of hydrophobic TM segments into the phospholipid bilayer 
TM2b and TM7 move apart, hence the designation as lateral gate. Recent structural data have 
revealed a TM segment entering the lipid phase through the opened lateral gate (Frauenfeld et 
al, 2011; Gogala et al, 2014) (Figure 2-2, panel B.).  
The two halves of SecY are clamped together on the ‘back’ side by the SecE subunit (Sec61γ in 
eukaryotes). In E.coli SecE consists of three TM segments and is essential for protein 
translocation. In other bacteria it is represented by only one TM helix and, in fact, much of the 
N-terminal part of E.coli SecE can be deleted without compromising protein translocation (de 
Gier & Luirink, 2001; Murphy & Beckwith, 1994) (Murphy and Beckwith 1994, de Gier and 
Luirink 2001). In the absence of SecE, SecY is unstable and is degraded (Kihara et al, 1995). The 
third subunit of the SecYEG trimer is SecG in bacteria, and its homolog in eukaryotes and 
archea is called Sec61β. Unlike the other two subunits, SecG is not evolutionary conserved. 
SecG in E.coli comprises two TM helices and occupies a position close to the lateral gate of 
SecY (Satoh et al, 2003; van der Sluis & Driessen, 2006). SecG is not essential for cell viability or 
protein translocation in E.coli; it was shown in vitro to stimulate protein translocation at low 
temperatures or when the proton-motive force (PMF) was compromised (Hanada et al, 1996; 
Nishiyama et al, 1996). Its main function was proposed to be connected with the SecA 






Figure 2-2 Structure of SecYEG 
A. Side view of the SecYEG from Methanococcus jannaschii ( (Van den Berg et al, 2004) PDB ID 1RHZ) illustrating 
the main structural elements of the complex according to the E.coli nomenclature. B. Top view from the cytosolic 
side of the SecYEG channel. 
 
It has been a long lasting debate in the field of protein translocation whether the SecYEG 
complex functions as a monomer or as a dimer. Finally it has been shown that a single copy is 
sufficient in vivo and in vitro for protein translocation and for membrane protein insertion 
(Becker et al, 2009; Cannon et al, 2005; Frauenfeld et al, 2011; Kedrov et al, 2011; Park & 
Rapoport, 2012). Nevertheless, different oligomeric states of the SecYEG have been observed 
by native electrophoresis (Bessonneau et al, 2002; Boy & Koch, 2009; Deville et al, 2011; 
Scheuring et al, 2005; Veenendaal et al, 2001), crosslinking experiments (Deville et al, 2011; 
Veenendaal et al, 2001) and electron microscopy (Breyton et al, 2002; Hanein et al, 1996; Mitra 
et al, 2005). The significance of these oligomeric states is yet to be elucidated.  
In the course of studying protein translocation and membrane insertion it was found that 
SecYEG interacts with several other partners: on the cytoplasmic site – SecA, FtsY, the 
ribosome and Syd, and in the membrane – SecDFYajC and YidC. The exact interaction site of 





only with a small fraction of SecYEG complexes (Pogliano & Beckwith, 1994). Based on the 
crystal structure of SecDF it was proposed that it transports protons from the periplasm to the 
cytosol (Scotti et al, 2000; Tsukazaki et al, 2011). YidC was first identified as a protein that 
copurified with the complex of SecYEG and SecDFYajC (Scotti et al, 2000). YidC is believed to 
facilitate the lateral exit of TM regions from SecY and has been found to crosslink to the 
lateral gate (Sachelaru et al, 2013).  
The motor protein SecA, which takes part in post-translational protein translocation through 
the SecYEG translocon, has been found to crosslink to the cytosolic loops of SecY (Mori & Ito, 
2006), and these contacts were confirmed by crystal structure data (Zimmer et al, 2008). The 
cytosolic loops of SecY are also binding platform for the ribosome and for FtsY. The cryo-
electron microscopy (cryo-EM) structure of the translating ribosome and SecYE in nanodiscs 
and biochemical studies show that the ribosome contacts the C4 and C5 loops of SecY via 23S 
rRNA helices 24, 50, 53 and 59 and proteins L23, L24 and L29 (Cheng et al, 2005; Frauenfeld et 
al, 2011; Kuhn et al, 2011; Raden et al, 2000). Also it interacts with the SecE subunit via the 
proteins L23 and L29 (Figure 2-3). On the other hand, FtsY also interacts with the C4 and C5 
loops of SecY and, thereby may occupy the binding site for the ribosome and SecA (Kuhn et al, 
2011).  
The main function of the SecYEG complex is to facilitate the membrane insertion of protein or 
their transport across the cytoplasmic membrane. How exactly the channel distinguishes 
between the substrates is not entirely clear. Biochemical data and molecular dynamics 
simulations have converged to a model where during cotranslational membrane insertion the 
ribosome is docked on SecY and in this way a continuous channel is formed from the peptidyl 
transferase center to the periplasm. The cytoplasmic part of SecY is mostly polar and functions 
as an extension of the ribosomal exit tunnel. This allows any secondary structure formed in 
the ribosome to be retained in the channel. The hydrophobic pore-ring stimulates helix 
formation.  
Thus, even sequences with low helix-forming tendency may enter the lipid phase in α-helical 
conformation (Gumbart et al, 2011b). This is energetically more favorable than embedding an 
extended peptide backbone (White & von Heijne, 2008). The pore ring helps to define energetic 





2011a; Junne et al, 2010). Molecular dynamics simulations of different nascent helices in SecY 
indicate that even when the lateral gate is closed, lipids can contact the helix with a 
probability that is proportional to the hydrophobicity of the helix. For hydrophobic TM 
sequences, the interaction with lipids appears to draw them into the membrane, whereas 
hydrophilic ones remain in the channel, thereby minimizing the contact with lipids (Gumbart 
et al, 2013).  
 
Figure 2-3 Structure and connections of the nanodiscs embedded SecYE to the ribosome 
Cryo-EM reconstitution of the E.coli RNC-SecYE embedded in nanodiscs ((Frauenfeld et al, 2011)  PDB ID 3J00 
and 3J01). Illustrated are the main connections of the ribosome and SecY, the 23S rRNA and the ribosomal 
proteins L23, L24 and L29. 
 
Overall the insertion and translocation of proteins by the SecYEG translocon is a complex 





protein synthesis, protein folding, and on protein-protein and protein-lipid interaction and 
recognition. Thus, it is important to deliver correct substrates to SecYEG. This is achieved by 
the signal recognition particle (SRP) and its receptor, SR, or FtsY in bacteria.  
 
2.2.2 SRP and membrane targeting of the ribosome 
SRP is evolutionary conserved and present in all three domains of life. In eukaryotes, SRP 
targets ribosomes synthesizing secretory or membrane proteins to the Sec translocon at the 
ER membrane, or to the thylakoids in chloroplasts. It is generally accepted that E.coli SRP is 
mainly responsible for the co-translational targeting of inner-membrane proteins to the 
SecYEG translocon (Beckwith, 2013). SRP differs in size and composition among species, the 
bacteria SRP contains the core of the ribonucleoprotein. It can functionally substitute its more 
complex eukaryotic SRP homologue (Bernstein et al, 1993; Powers & Walter, 1997). Bacterial 
SRP is comprised of a protein part, the Ffh protein (homologue of SRP54, the only 
evolutionary conserved protein in the eukaryotic SRP particle), which binds to 4.5S RNA (7S 
RNA in eukaryotes) (Bernstein et al, 1993; Powers & Walter, 1997). The 114 nucleotide SRP 
RNA adopts a hairpin structure. In E.coli it is required for cell viability (Brown & Fournier, 
1984; Hsu et al, 1984) (Figure 2-4, panel A.). Nevertheless, truncated RNA containing only 44 
nucleotides from the apical hairpin, i.e. part of helix 8, is sufficient to sustain cell growth 
(nomenclature according to (Batey et al, 2001; Zwieb et al, 2005)). Helix 8 includes two 
evolutionary conserved regions that are important for the in vivo activity of SRP. The first one 
comprises two internal loops near the hairpin tip where the SRP M domain binds (Batey et al, 
2000). The second is the GGAA tetraloop (GNRA in bacteria (Rosendal et al, 2003)), which is 
located at the tip of the hairpin and is essential for SRP-FtsY complex formation (Jagath et al, 
2001; Shen et al, 2012; Zhang et al, 2008).  
Ffh comprises two functional domains connected with a flexible linker. The C-terminal M 
domain binds 4.5S RNA and the signal sequence (Batey et al, 2000; Hainzl et al, 2011; Janda et 
al, 2010; Keenan et al, 1998). It is preceded by the NG domain that is composed of a helical N 
domain and the G domain, which binds and hydrolyzes GTP. The NG domain of Ffh interacts 
with the homologous NG domain of FtsY, and the N domain binds to ribosomal proteins L23 





established between the M domain, the ribosomal RNA, and the ribosomal protein L22. These 
interactions have been characterized via crosslinking analysis (Gu et al, 2003; Pool et al, 2002) 
and cryo-EM reconstitutions (Halic et al, 2006a) (Figure 2-4, panel C.). Ribosomes synthesizing 
proteins destined for membrane insertion are targeted by SRP in an early stage of translation. 
SRP binds with high affinity to ribosomes synthesizing any protein already when the first 30 – 
35 amino acids are in the ribosomal tunnel. Later, when the peptide emerges from the tunnel 
SRP recognizes whether the peptide encodes a signal-anchor sequence (SAS), or not. When it 
encodes one then SRP also binds to its substrate, and translation continues. Since the 
interaction of SRP with the isolated peptide is weak with a Kd in the micromolar range 
(Bradshaw 2009), primarily it is the multiple interactions with the ribosome that allow the SRP 
to bind to the ribosome in a wide range of affinities, from Kd = 100 nM to vacant ribosomes to 
Kd = 1 nM to ribosomes that have the exit tunnel filled or expose a SAS (Bornemann et al, 
2008; Flanagan et al, 2003; Holtkamp et al, 2012a). 
N-terminal SAS are similar in eukaryotes and prokaryotes. They share a common architecture 
with a short positively charged N-terminal region, a central hydrophobic region and a C 
terminal slightly polar region (von Heijne & Abrahmsen, 1989). The SAS does not have a 
conserved amino acid sequence, but is typically 8 – 12 amino acids long and adopts an α-
helical structure (Hegde & Bernstein, 2006). The first proof that the M domain of SRP 
functions as a signal sequence binding site was from crosslinking studies (Krieg et al, 1986; 
Zopf et al, 1990). The M domain is methionine-rich and can provide a hydrophobic 
environment to accommodate hydrophobic signal peptides in a sequence-independent 
manner. The crystal structures of Ffh (Keenan et al, 1998) and SRP54, fused to an SAS (Hainzl 
et al, 2011; Janda et al, 2010), showed that the SAS binds in a hydrophobic groove of the M 
domain. Another important region of the M domain is the flexible fingerloop, which lines the 
signal peptide binding groove. It mediates the information of the binding of the SAS to M 






Figure 2-4 Structure of SRP and its contacts with the ribosome and the SAS 
A. Representative secondary structure of E.coli 4.5S RNA. It comprises helix 8 (numbering according to (Zwieb et 
al, 2005)), previously assigned as domain IV, and helix 5 (domain II). The conserved motives are highlighted in 
grey. Canonical Watson-Crick base pairs are represented by lines, non-canonical Watson-Crick base pairs by plus 
signs and G-U pairs by filled circles (figure taken from SRPDB (Zwieb, 2011)). B. X-ray structure of the 
Methanococcus jannaschii SRP ((Hainzl et al, 2007) PDB ID 2V3C). C. Cryo-EM reconstruction of the E.coli RNC-
SRP complex ((Halic et al, 2006a) PDB ID 2J28). 
 
2.2.3 Interaction of SRP with FtsY 
In the cell SRP rapidly scans the translating ribosomes until it recognizes a ribosome that has 
the exit tunnel filled or exposes an SAS which stabilizes the complex about 100-fold. After 
several discrete conformational changes it adopts a more opened conformation and switches 
to targeting mode. In this mode the recruitment of its receptor, FtsY is accelerated (Holtkamp 
et al, 2012a).  
The complex formation of SRP and FtsY is mediated first by the 4.5S RNA of SRP and second 





the proteins is facilitated by the tetraloop of 4.5S RNA (Jagath et al, 2001; Spanggord et al, 
2005; Zhang et al, 2008), followed by the interaction of the NG domains of SRP and FtsY with 
one another. This second step requires that both proteins have GTP bound. At the final stage 
of assembly the complex travels 100 Å to the 3’-distal end of the RNA. There mutual activation 
of the GTP hydrolysis is triggered by the alignment of the GTP-binding pockets and the 
insertion of the catalytic G83 nucleotide from the SRP RNA (Figure 2-5). This movement on 
the 4.5S RNA does not occur when the complex is assembled on RNCs, but at a later stage the 
presence of SecYEG releases the complex (Shen et al, 2013; Voigts-Hoffmann et al, 2013). 
Additionally the targeting complex of the RNC-SRP-FtsY could be influenced by the 
interaction of FtsY with the membrane and SecYEG (Braig et al, 2009; Mircheva et al, 2009) by 
triggering conformational changes in the A domain (Stjepanovic et al, 2011b).  
As mentioned above, both it is the protein component of SRP, Ffh, and FtsY are GTPases 
which form the regulatory center of the SRP-targeting pathway. In contrast to the canonical 
Ras-like GTPases, the SRP-related GTPases do not require GTPase-activating factors (GAPs), 
or nucleotide exchange factors (GEFs) for their function. They bind GTP and GDP with similar 
affinities (around 1 – 2 µM) and readily exchange GDP for GTP (Jagath et al, 1998; Leipe et al, 
2002). Thus, both Ffh and FtsY belong to the SIMIBI class of GTPases, which is part of the 
superfamily of P-loop proteins (Leipe et al, 2002). In contrast to the Ras-like G proteins, which 
have a central six-stranded β-sheet and one antiparallel strand, the SIMIBI proteins have an 
exclusive parallel seven-stranded β-sheet architecture. This structure results in a particular 
orientation of the switch-1 region. The switch-1 and switch-2 regions are responsible for 
transferring the conformational change brought about by GTP hydrolysis to other parts of the 
protein.  
SRP and FtsY share the conserved NG domain organization. The G domain has a unique α-β-α 
insertion box (IBD) that is located between the switch-1 and switch-2 regions. In complex with 
GTP SRP and FtsY form a quasi-symmetric heterodimer via their NG domains. The GTP-
binding pockets align and form a composite active site. The IBD loops of each protein close the 
catalytic sites from the top and contribute to the formation of the active site. Ffh Arg141 and 
Gln147 and FtsY Arg333 and Gln339 position the GTP for hydrolysis and provide electrostatic 





another, although full GTPase stimulation requires the environment of the membrane and, 
most likely, the translocon (Egea et al, 2004; Focia et al, 2004). 
 
 
Figure 2-5 The complex of SRP and FtsY 
A. Structure of the NG domains Ffh-FtsY heterodimer in complex with GDPCP (green) forming a composite 
active site ((Egea et al, 2004) PDB ID 1RJ9). B. Structure of the SRP-FtsY heterodimer forming a protein-RNA 
composite active site ((Ataide et al, 2011) PDB ID 2XXA). 
 
According to a recent model based on single-molecule and crystallographic data, the active 
site is completed by a catalytic guanine residue (G83) from the 3’-distal end of the 4.5S RNA. 
The exact mechanism of catalysis is yet unknown, given that this nucleotide is not conserved 
(Voigts-Hoffmann et al, 2013). Though, the truncation of the distal end compromises the 






2.2.4 FtsY – structure and function 
It is generally thought that the main function of the SR is to tether the complex of the 
ribosome and the SRP to the cytoplasmic membrane and to SecYEG. In eukaryotes, SR 
consists of two subunits: SRβ is an integral membrane protein which associates with SRα 
which, in turn, binds to the ribosome-SRP complex. In contrast, the bacterial SR is a single 
protein, called FtsY, which is homologous to SRα (Luirink et al, 1994); so far no homolog of 
SRβ has been identified in bacteria. The functional NG domain of FtsY comprises the N 
domain (amino acids 198 – 284) and the G domain (amino acids 292 – 497) and is preceded by 
an acidic A domain (amino acids 1-197) (Figure 2-6) (Bernstein et al, 1989; Romisch et al, 1989). 
Among the various prokaryotes, the A domain is highly divergent in size and charge. Based on 
sequencing data it has been classified into four categories: (a) highly negative with high 
homology to E.coli FtsY; (b) moderately charged with low homology to E.coli FtsY; (c) very 
short (less that 30 amino acids) and positively charged; (d) no similarity to the A domain of 
E.coli FtsY with a single, putative TM helix. In contrast, the NG domain is highly conserved. 
There is no structural information on the A domain, and in silico analysis predicts it to be 
rather unstructured, except for amino acid 1-14 which are predicted to form an α-helix 
(Pollastri et al, 2002). Deuterium exchange experiments have also confirmed that the A domain 
is rather unstructured (Stjepanovic et al, 2011b). 
Although in cell extracts FtsY seems to be about equally distributed between cytosol and 
membrane (Luirink et al, 1994), in vivo data suggest that FtsY is primarily located at the 
membrane (Mircheva et al, 2009). There FtsY is involved in protein-lipid and protein-protein 
interactions (Angelini et al, 2006; Millman et al, 2001). Furthermore, it has been shown that 
FtsY interacts physically and functionally with SecYEG (Angelini et al, 2005; Kuhn et al, 2011). 
In addition ample data has been gathered on the interaction of FtsY with lipids. It 
preferentially binds to anionic phospholipids (e.g. phosphatidyl glycerol) in a salt-sensitive 
manner with an optimum around 100 mM. Binding to phospholipids and lipid vesicles leads to 
changes in the structure of FtsY (de Leeuw et al, 2000; Reinau et al, 2010) and can activate its 
GTPase function, at least to some extent (de Leeuw et al, 2000; Lam et al, 2010). Two conserved 
sites at the A domain were proposed to be the main lipid interaction sites. The first is located 
at the N terminus of the A domain (amino acids 1 – 14) and the second at the interface 





suggest that these regions bind preferentially to anionic phospholipids and the region 
connecting them does not contribute to the lipid interaction. However, the two lipid-binding 
regions apparently provide stable binding to the membrane which is comparable to the 




Figure 2-6 Structure of FtsY 
Schematic representation of the domain organization of FtsY (top panel ) crystal structure of the E.coli FstY-
NG+1 in complex with GMPPNP (bottom panel). The MTS in the structure forms an α-helix, which is shared 
between the N and the A domain. A hypothetical localization of the A domain is designated in red dashed line. 
((Reyes et al, 2007) PDB ID 2Q9B). 
 
Regarding the second amphiphilic region between the A and N domain, it has been shown 
that an FtsY construct which encompasses the NG domain and Phe196 of the A domain (FtsY-
NG+1) can rescue the otherwise severe ΔFtsY phenotype. In comparison, the NG domain 
construct lacking this single amino acid could not rescue the ΔFtsY phenotype and was not 





crystal structure of these constructs revealed that the FtsY-NG+1 variant forms a helix at its N 
terminus due to the presence of Phe196, but in the case of FtsY-NG the N terminus remains 
unstructured. Thus, this second amphiphilic region belonging to both A domain and N domain 
was designated as the membrane targeting sequence (MTS) (Parlitz et al, 2007).  
 
2.2.5 Membrane localization of FtsY and interaction with SecYEG 
In the past most of the studies on FtsY addressed the localization of FtsY in the cells and the 
potential of FtsY to bind to lipids. The main reason was that E.coli FtsY does not have an 
additional integral membrane binding partner as in eukaryotes. Nevertheless, FtsY exists as a 
peripheral membrane protein that interacts with the membrane phospholipids via two 
conserved sequence in the A domain (Braig et al, 2009; Weiche et al, 2008). In addition it has 
been shown that FtsY also has a protein binding partner at the membrane (Millman et al, 
2001). Furthermore, the study of the separate domains of FtsY has indicated that both seem to 
have affinity to the membrane. In vivo the A domain competes with full-length FtsY for 
membrane association, whereas the NG domain does not (de Leeuw et al, 1997). The protein 
binding partner of FtsY at the membrane was identified as SecYEG. This finding suggested 
how FtsY guides the RNC-SRP complex to an available SecYEG channel (Angelini et al, 2005). 
Later crosslinking studies have pinpointed the A domain of FtsY as the main site of interaction 
with the SecY subunit (Kuhn et al, 2011).  
Currently, there are two models regarding the cellular localization of FtsY. The first one 
assumes that FtsY exists in a cytosolic and membrane-bound form. This model is based on cell 
fractionation and liposome binding experiments which show that FtsY is bound weakly to the 
membrane (Lam et al, 2010; Luirink et al, 1994; Parlitz et al, 2007). The second model is based 
on in vivo localization studies which indicate that FtsY is mostly associated with the 
membrane and on the observation that membrane targeting of RNC-SRP complexes via 







2.3 Aim of this study 
According to the current model of cotranslational membrane targeting of proteins, membrane 
proteins are early recognized during their synthesis by the SRP. After binding to the ribosome 
and the SAS, SRP recruits its receptor FtsY. The receptor tethers the RNC-SRP complex to the 
membrane, where the RNC is transferred to the SecYEG channel in a GTP-controlled manner. 
This process has been extensively studied in the past 30 years. However, there are still open 
questions concerning the localization of FtsY when it binds the RNC-SRP complex; the 
interaction of FtsY and SecYEG; the exact mechanism and timing of the GTP hydrolysis; the 
transfer of the RNC on SecYEG.  
In this project we set out to investigate one of the least understood aspects of the SRP 
pathway – the interaction between FtsY and SecYEG and how this interaction changes after 
the RNC is transferred on SecYEG. The first part of the project aim at establishing an efficient 
expression and purification protocol for SecYEG that yield high amounts of pure complex 
suitable for biochemical studies. Furthermore, the incorporation of SecYEG into nanodiscs 
(SecYEG(ND), adopting a protocol from the literature. Here the main aim was to isolate the 
monomeric translocon in a biochemically defined form that would allow quantitative 
biochemical and biophysical experiments. For monitoring the interaction between FtsY and 
SecYEG, fluorescence labels were to be introduced into both partners to allow fluorescence 
resonance energy transfer (FRET) measurements. At the beginning of the project little was 
known about the interaction site of FtsY and SecYEG, which presented a challenge. Major 
aims were to characterize the interaction of FtsY and SecYEG(ND) by measuring the affinity 
and kinetic stability of the complex. Following up the finding that FtsY interacts with the 
lipid-embedded translocon via two interaction sites, the contribution of the NG and A 
domains of FtsY to the binding to SecYEG(ND) was to be determined. This aim included the 
characterization of conformational rearrangements between the domains of FtsY upon binding 
to SecYEG. In the second part of the project the main question was whether FtsY remains 
associated with the translocon after the RNC is transferred on the SecYEG translocon,. Finally, 








3.1 SecYEG incorporation into nanodiscs  
In this project, the main focus is on the SecYEG translocon and its interaction with the SRP 
receptor, FtsY and the ribosome. In order to monitor these interactions, we needed to handle 
SecYEG in an environment that mimicked the cytoplasmic membrane as closely as possible 
and should also provide SecYEG in a biochemically defined manner, allowing for quantitative 
measurements. The in vitro work with membrane proteins requires an adequate hydrophobic 
environment. Some of the commonly used methods include the addition of small amounts of 
detergents or embedding the proteins into lipid vesicles (e.g. proteoliposomes or inverted 
vesicles). The use of detergents avoids problems of aggregation and precipitation of the 
membrane proteins, but could potentially influence the interaction between binding partners. 
The use of proteoliposomes and inverted vesicles has the advantage that the proteins are in 
their native lipid environment which very much resembles the membrane of the cell. However, 
these methods have little control over the actual concentration and orientation of the proteins 
in the lipid bilayer. This is especially important when the membrane proteins have transport 
functions, such as membrane transporters. Another obstacle is that different oligomeric states 
cannot be controlled. In conclusion, the current methods for handling membrane proteins 
predominantly allow for qualitative measurements.  
In this work, we have applied the recently developed method for embedding membrane 
proteins into nanodiscs (Alami et al, 2007; Dalal & Duong, 2010; Denisov et al, 2004). This 
technique allows the insertion of membrane proteins into a small lipid disc which is held 
together by two amphipathic α-helical proteins (membrane scaffold proteins – MSP) derived 
from apolipoprotein A-I which wraps around lipids in HDL. The discs can vary in size 
depending on the length of the scaffold proteins. The advantage of this method is that 
monomeric proteins are inserted into a membrane-like lipid environment. Since the discs 
engulf no lumen, the directionality of protein insertion is not an issue anymore, as proteins 
incorporated into nanodiscs are accessible from both sides. Thus, nanodiscs allow for the 
quantitative study of proteins in a biochemically defined system.  
First, we established an expression and purification system for SecYEG, based on a plasmid 





genes coding for SecYEG were under the control of a single trc promoter. For purification of 
SecYEG, SecE carried a C-terminal His6-tag. The conventional E.coli strains for the expression 
of membrane proteins (CD41(DE3) and CD43(DE3)) did not yield sufficient amounts of 
protein. Therefore, we used the Lemo21(DE3) strain which is optimized for the overexpression 
of membrane proteins (Wagner et al, 2008). The growth and expression of SecYEG was 
performed at 37°C and the induction time was cut down from 16 to 4 hours. 
SecYEG was purified according to an original protocol from the laboratory of Hans-Georg 
Koch (personal communication) with several modifications. We followed the centrifugation 
steps for separation of crude membranes, but added a cation exchange column as a third 
purification step. The cell debris was removed for 20 min at 20 000 x g and the membrane 
fraction was pelleted for 2 h at 150 000 x g. Afterwards, the membranes were solubilized in 
buffer containing 1 % DDM and 1 M NaCl. SecYEG was next purified on a Ni-affinity column, 
followed by a cation exchange chromatography on a HiTrapSP-HP column. This last step of 
purification removed some higher molecular weight contaminations (Figure 3-1).  
In most of the experiments SecY was labeled at a specific cysteine via thio-maleimide coupling 
reaction. After completing the labeling and removing the unreacted dye, SecYEG was used for 
the formation of nanodiscs. 
 
Figure 3-1: SecYEG purification.  
The bacterial membranes containing SecYEG were pelleted and later solubilized by 1 % DDM. A. Afterwards the 
solubilized membranes we loaded on HisTrap column and SecYEG was eluted with 200 mM imidazole. B. The 
eluted fractions were rebuffered into low salt buffer and applied on SP cation exchange column. SecYEG was 





The assembly of the nanodiscs was initially performed according to Alami et al, 2007. In order 
to increase the homogeneity of the nanodiscs we amended the ratio between SecYEG, MSP 
and the lipids, from 1:4:60 to 1:2:30 (SecYEG:MSP:lipids). To purify the complex of SecYEG in 
nanodiscs from excess of lipids we applied the sample on a 170 ml size exclusion column 
(Superdex 200). The routine quality control included clear native PAGE (CNP) and SDS-PAGE 
of the chromatographic peaks (Figure 3-2). The discs containing SecYEG (SecYEG(ND)) eluted 
in the peak at 0.55 column volume (CV). During the formation of nanodiscs containing 
SecYEG a small amount of empty discs was also formed. It eluted in a later peak at 0.65 CV.  
 
Figure 3-2 Purification and analysis of nanodiscs containing SecYEG.   
A. To purify the complexes of SecYEG in nanodiscs (SecYEG(ND)) Superdex 200 size-exclusion chromatography 
was used. In this purification step SecYEG(ND) was separated from the excess lipids and additionally formed 
empty nanodiscs. B. To analyze the homogeneity of SecYEG(ND) the elution peaks were resolved by clear native 
PAGE. C. The presence of SecYEG and MSP in the complexes was verified by SDS-PAGE.  
 
In some preparations, higher molecular weight species were resolved on the CNP from the 
same chromatographic peak. In order to verify whether these size differences were due to the 
presence of an extra copy of SecYEG or to differences in lipid content, we analyzed the gel 
bands by mass spectrometry. The results confirmed that the bands contained MSP and 
SecYEG. We also quantitated the ratio between SecY and MSP using intensity based absolute 
quantification (iBAQ) (Smits et al, 2013). In all bands, the SecY:MSP ratio was 1:2. Thus our 
nanodisc preparations contained monomeric SecYEG (Figure 3-3, panel A.). Initially we also 





(Denisov et al, 2004). We also quantitated the composition of these discs by iBAQ, because 
their size allows the embedding of two copies of SecYEG. In our preparations of SecYEG(NDE) 
the translocon was present as monomer and the exhibited higher molecular weight due to the 
larger amount of lipids (data not shown) compared to the standard 10 nm SecYEG(ND). In 
addition we verified the homogeneity of the SecYEG(ND) using negative staining electron 
microscopy (EM). The disc particles appeared relatively small, but regular in size, and no 
aggregates were observed (Figure 3-3, panel B.) Thus, we concluded that the difference in the 
molecular weight observed on the CNP of the same chromatographic peak result from small 
difference in the lipid amount, which change the electrophoretic mobility, but do not affect 
the overall appearance of the nanodiscs.  
 
Figure 3-3 Characterization of SecYEG(ND) by iBAQ negative-staining EM  
A. Quantification of the number of SecYEG molecules per nanodiscs by subjecting to mass spectrometry gel 
bands from clean native PAGE and analyzing the results by iBAQ. The analysis was performed by Ilian 
Atanossov. B. Negative stain electron micrograph of SecYEG(ND) which represents nanodiscs of similar shape 
and size. The imaging was performed by Andruis Krasauskas.  
 
3.2 Binding of FtsY to SecYEG 
To monitor the binding of FtsY to SecYEG, we used fluorescence resonance energy transfer 
(FRET) between SecY labeled at position S111C with MDCC (SecY(111MDCC)EG) and FtsY 
labeled with an acceptor dye, Bodipy FL at position F196C (FtsY(196Bpy)). The labeling 
positions and the donor- acceptor pair are the same throughout this work (Figure 3-4, panel 
B.) unless stated otherwise. We compared the fluorescence change of SecY(111MDCC)EG 





with detergent added, (b) without detergent, and (c) SecY(111MDCC)EG in nanodiscs 
(SecY(111MDCC)EG(ND). We observed a 30% decrease in the donor fluorescence in the case 
of SecY(111MDCC)EG(ND), compared to SecY(111MDCC)EG without detergent. In the 
presence of the detergents Nikkol and/or DDM (Akopian et al, 2013a; Peluso et al, 2001; Shen 
et al, 2012) no significant change in donor fluorescence was observed Figure 3-4, panel B.). This 
indicated that FtsY binds to SecY(111MDCC)EG in a similar fashion as to 
SecY(111MDCC)EG(ND), but the presence of detergents impairs complex formation. 
 
Figure 3-4 FtsY binding to SecYEG in different environments.  
A. FRET pair of SecYEG ((Van den Berg et al, 2004) PDB ID 1RHZ) labeled with MDCC and FtsY (structure of 
FtsY-NG+1 PDB ID 2Q9B) labeled with Bpy. B.  Comparison of the FRET efficiency of FtsY(196Bpy) binding to 
SecY(111MDCC)EG embedded in nanodiscs or only in buffer with or without added detergent. 
 
3.2.1 Affinity of FtsY binding to SecYEG 
The previous results raised the question whether the presence of lipids has an influence on the 
binding of FtsY to SecYEG. In order to test this, we measured the affinity of FtsY(196Bpy) to 
SecY(111MDCC)EG when (a) SecYEG was in solution, (b) embedded in nanodiscs with 10 nm 
diameter (SecYEG(ND)), or (c) in extended 12 nm nanodiscs (SecYEG(NDE)), assembled with a 
longer construct of the MSP protein, which contain more lipids than standard SecYEG(ND). 
We observed no difference in the affinities dependent on the size of the discs (Kd = 0.18 ± 0.02 





µM) (Figure 3-5).In order to check if the fluorophore labels could have influenced the 
measurements, we made a comparison with a label-free method – ITC. The affinity of 0.24 µM 
measured by ITC (J. Jöckel, personal communication) was in the same range as measured by 
fluorescence. This indicated that the labels did not interfere with the interaction of the two 
binding partners.  
 
Figure 3-5 Affinity of FtsY binding to SecYEG.  
Affinity titration of SecY(111MDCC)EG in solution without detergent, in 10 nm nanodiscs (SecYEG(ND), or in 12 
nm nanodiscs (SecYEG(NDE) with FtsY(196Bpy). Kd values in Table 2 – 1.  
 
Previous work has shown that FtsY binds better to inner-membrane vesicles (INVs) when 
bound to a non-hydrolyzable GTP analog (GMPPNP) (Angelini et al, 2006). We tested whether 
FtsY in complex with the different guanine nucleotides has a different affinity to 
SecY(111MDCC)EG(ND). SecY(111MDCC)EG(ND) was titrated with FtsY(196Bpy) in the 
presence of GDP, GTP, GMPPNP or in the absence of nucleotide. The affinity of FtsY 
remained the same independent of the nucleotide (Table 3-1).  
In conclusion, we show that FtsY binds to SecYEG with high affinity (Kd ≈ 0.2 µM). The affinity 
of the complex is about the same for SecYEG free in solution, or when the translocon is 
embedded into nanodiscs. Since SecYEG is a membrane protein, the nanodiscs seem to be a 





Table 3-1: Affinity of FtsY binding to SecYEG 
FtsY binding to Kd, µM 
SecYEG(ND) 





SecYEG(NDE) 0.13 ± 0.02 
SecYEG without 
detergent* 0.35 ± 0.04 
SecYEG in detergent** no binding 
SecYEG(ND)  
ITC data*** 0.3 
*No detergent present in the reaction buffer 
**0.05% DDM, 0.01% Nikkol or a combination of both 
*** the ITC measurements were performed by Johannes Jöckel 
 
3.2.2 Interaction of FtsY with empty nanodiscs 
Although we have determined the affinity of FtsY to SecYEG(ND), it was still unclear what is 
the contribution of the lipid binding. Previous work suggested that FtsY has two potential 
interaction sites at the membrane and each one of them is sufficient for the membrane 
localization of FtsY. One is a trypsin-sensitive component and the second is the membrane 
lipids (Millman et al, 2001).  
We set out to characterize the interaction of FtsY with lipids using empty nanodiscs (ND). 
Since the nanodiscs were not labeled, the binding of FtsY to ND was monitored indirectly in a 
competition experiment with SecYEG(ND). We measured the affinity between 
SecY(111MDCC)EG(ND) and FtsY(196Bpy) upon addition of increasing concentrations of ND 





affected only the amplitude of the fluorescence change. This indicated that the ND is a 
noncompetitive binding partner.  
Since, the effect of the ND is to make it appear as if less total FtsY is present by binding to it, 
then by analyzing the change of the fluorescence amplitude an estimate can be obtained for 
the apparent affinity (𝐾𝑑𝑎𝑝𝑝) of FtsY to ND. To calculate it the final fluorescence levels were 







  (Segel, 1993), where 𝐹𝑁𝐷 is the fluorescence level in the presence of ND, F is the 
fluorescence level in the absence of ND and ND is the concentration of empty nanodiscs in the 
titration.  
 
Figure 3-6 FtsY binding to SecYEG(ND) in the presence of ND.  
A. SecY(111MDCC)EG(ND) titrated with FtsY(196Bpy) in the presence of increasing concentrations of ND. B. 
Plot of the final fluorescence levels of the titrations versus the ND concentration gives an estimate for the affinity 
of FtsY to ND.  
 
Therefore, FtsY binds equally well to empty nanodiscs as to SecYEG embedded in nanodiscs. 
In this sense we could not distinguish whether FtsY binds to SecYEG or the lipids and which 
interaction is more dominant. This agreed with the previous observation that each of the two 
interaction sites of FtsY at the membrane are equal in contribution to the localization of FtsY. 
Furthermore, the noncompetitive character of the binding partners suggested that probably 





3.2.3 Stability of the FtsY-SecYEG(ND) complex 
It has been long disputed in the literature whether FtsY is mostly localized at the membrane 
or in the cytosol (de Leeuw et al, 1997; de Leeuw et al, 2000; Luirink et al, 1994; Parlitz et al, 
2007; Weiche et al, 2008). Importantly, only the membrane bound FtsY is able to induce release 
of SRP from the signal anchor sequence (SAS) (Valent et al, 1998). Recently, this question has 
been investigated using in vivo GFP-tagged FtsY and fluorescence microscopy (Mircheva et al, 
2009). Their results show that FtsY is predominantly localized at the membrane, contrary to 30 
- 50% as previously assumed (Luirink et al, 1994; Parlitz et al, 2007). We wanted to test the 
stability of the complex between FtsY and SecYEG(ND) by using our FRET setup in a stopped-
flow apparatus. In the experiment, FtsY(196Bpy) was displaced from SecY(111MDCC)EG(ND) 
by addition of a 10-fold excess of unlabeled FtsY.  
 
Figure 3-7 Stability of the complex between SecYEG(ND) and FtsY.  
The complex of SecY(111MDCC)EG(ND) and FtsY(196Bpy) was pre-formed. Dissociation was induced by rapidly 
mixing the complexes with a 10-fold excess of unlabeled FtsY, and the change in fluorescence of Bpy was 
monitored in a stopped-flow apparatus. 
The fluorescence trace from the change of the acceptor fluorescence was fitted to a three 
exponential decay (Figure 3-7). The first two exponents comprised 70% of the main amplitude 
change. The first phase, a fast dissociation step of 14 s-1 was followed by a slower second step 
of 0.4 s-1. The third phase was too slow to be physiologically relevant (0.008 s-1). Thus, we 





SecYEG(ND) in two steps, where the second step is rate-limiting with a half-life time of 1.7 s, 
indicating a limited stability of the complex. Alternatively, the two-step dissociation could 
indicate different population of complexes or that there are two binding sites of FtsY on 
SecYEG(ND). The latter possibility would agree with previous results which suggested that 
FtsY is associated with the membrane through both protein-lipid and protein-protein contacts 
(Angelini et al, 2006; Braig et al, 2009; Millman et al, 2001). Further studies have shown that 
FtsY binds to lipids via its membrane targeting sequence (MTS) located between its A and N 
domains (Millman & Andrews, 1999; Stjepanovic et al, 2011b) and also is associated with SecY 
via its A and N domains (Angelini et al, 2005; Kuhn et al, 2011). As to the localization of FtsY in 
the cell, the limited stability of the FtsY complex with the ND-embedded translocon indicates 
that part of FtsY may dissociate from the complex during cell extract preparation, explaining 
the considerable amount of free FtsY observed during cell fractionation (Luirink et al, 1994).  
3.2.4 Binding of FtsY NG and A domains to SecYEG(ND) 
To further dissect the way FtsY binds to SecYEG(ND), we used four FtsY constructs and 
compared them to full-length FtsY (Figure 3-8). The first two constructs were well-studied 
variants of the NG domain: FtsY-NG+1 and FtsY-NG. Both constructs bind GTP and GDP with 
comparable affinities to FtsY, interact with SRP and stimulate the GTPase function of the 
complex (Bahari et al, 2007). FtsY-NG comprises amino acids from Ala197 to the end of the C 
terminus 497. FtsY-NG+1 included also Phe196 at the N-terminus, which completed the MTS 
that is crucial for lipid association (Parlitz et al, 2007; Stjepanovic et al, 2011b). It has been 
shown for these two variants that the ΔFtsY phenotype can be rescued by FtsY-NG+1 whereas 
FtsY-NG cannot (Eitan & Bibi, 2004). The other two constructs were variants of the FtsY A-
domain. FtsY-A197 comprised the first 197 N-terminal amino acids and FtsY-A208 the first 208. 
The main difference between the two variants was that FtsY-A197 included only one 
amphiphilic sequence at position 1 – 14 and FtsY-A208 included both: 1 – 14 and 195 – 207 – 
MTS. Previous work has indicated that that both sequences contribute to the lipid binding of 







Figure 3-8 FtsY constructs. 
A. Schematics of the FtsY constructs used in this work, B. Structure of FtsY-NG+1 in complex with GMPPNP (blue) (  (Reyes 
et al, 2007) PDB ID 2Q9B). The A domain is not present in the structure.  
To purify the A-domain constructs and to ensure that they are not proteolytically degraded in 
the cell, we cloned them in a pSUMO vector with an N-terminal His6-tag and a SUMO-
cleavage site between the tag and the first methionine.  
First, we examined the binding of all four constructs to SecYEG(ND) and determined their 
affinity to SecY(111MDCC)EG(ND). Binding was monitored by either the fluorescence change 
of MDCC induced by FtsY-NG and NG+1, or by FRET between MDCC and Bpy at position 
167 in FtsY-A197 and FtsY-A208. All constructs bound with Kd values that were comparable to 
the binding of full-length FtsY, i.e. around 0.2 µM (Table 3-2). Thus, despite of the substantial 
truncations the affinities were not affected significantly. These data suggested that the two 
domains individually bound strongly to SecYEG(ND), but their contribution did not appear as 
additive when full-length FtsY was bound. This suggested that there was an additional event 
that consumes part of the binding energy. One possibility is that there is an interaction 
between the NG and A domains which is disrupted upon binding. In such a scenario, the inter-
domain rearrangement will require extra energy. Following, we examine whether the isolated 





Table 3-2: Affinity of FtsY NG and A domains in binding to SecYEG(ND) 
FtsY construct Kd, µM 
FtsY 0.18 ± 0.02 
FtsY-NG+1 0.15 ± 0.02 
FtsY-NG 0.23 ± 0.02 
FtsY-A208 0.20 ± 0.01 
FtsY-A197 0.30 ± 0.02 
 
3.3 Interaction of the FtsY-NG domain with the FtsY-A domain 
3.3.1 Affinity of the FtsY-NG domain binding to the FtsY-A domain 
We set out to test whether the NG and A domains of FtsY interact. We inserted fluorescent 
dyes for FRET measurements into the A domain at position A167C and labeled it with Bodipy 
FL as donor (FtsY-A197(167Bpy) and FtsY-A208(167Bpy)). FtsY-NG was labeled with the non-
fluorescent acceptor dye QSY9 at position V342C (FtsY-NG(342QSY9).  
 
Figure 3-9 Binding of the FtsY-NG and the FtsY-A domain.  






For these measurements, we only used the FtsY-NG construct. It represents the GTPase 
domain and has the least sequence overlap with the A domain constructs. In fact, as expected, 
the two domains formed a complex, and the affinity of the complex was very high, Kd = 9 nM. 
Thus, the interaction between the domains is strong enough to explain the energy loss 
observed above, although the match was not quantitative. 
To clarify if the interaction between the NG and A domain can explain the non-additive effect 
on the affinity of FtsY and SecYEG(ND), we calculated the free energy of each interaction 
(ΔG°) using the measured Kd values. The results are summarized in Table 3-3. If the 
contributions of the NG and A domains for the binding of FtsY were additive, then the ΔG° of 
the interaction between FtsY and SecYEG(ND) should be the sum of the ΔG° values of the 
individual interactions, about -15 kcal/mol. The difference between the calculated and the 
experimentally measured free energy of FtsY binding (ΔΔG°) is approximately 8 kcal/mol. This 
energy is not far from the free energy of the interaction between the two domains, – 9.6 
kcal/mol, supporting the model. The discrepancy between the calculated and the measured 
ΔΔG° may be attributed to a somewhat different behavior of the isolated domains, compared 
to being connected by a linker, which may also change conformation upon domain separation.  
Table 3-3 Free energies of the binding of SecYEG(ND) to FtsY and of the interaction between FtsY NG 
and A domains 








FtsY domain interaction  
FtsY-NG:FtsY-A -9.6 
* ΔG°= RTlnKd, where R is the universal gas constant (1.98 cal/K 
mol), T is the absolute temperature in Kelvin and Kd is the 






3.3.2 Conformational change of FtsY upon binding to SecYEG(ND) 
We measured FRET between FtsY-A(167Bpy) and FtsY-NG(342QSY9) to determine whether 
the binding to SecYEG(ND) or to ND influences the interaction between the FtsY domains. 
The titrations of the complexes of FtsY-A197(167Bpy) and FtsY-NG(342QSY), and FtsY-
A208(167Bpy) and FtsY-NG(342QSY9) with SecYEG(ND) or ND showed similar affinities 
(Figure 3-10). The change of FRET accompanying complex formation indicates that the 
domains of FtsY separate from each other upon binding to SecYEG(ND) or to ND. The analysis 
of the titrations suggested once more that the affinity of FtsY binding to SecYEG(ND) or to 
ND is about the same (Kd = 1 ± 0.2 µM).  
 
Figure 3-10 Interaction of the complex of FtsY-NG and FtsY-A with SecYEG(ND) or ND. 
The 1:1 complex of FtsY-A197(167Bpy) and FtsY-NG(342QSY9) or of FtsY-A208(167Bpy) and FtsY-NG(342Bpy) at 0.05 µM final 
concentration was titrated with empty ND (A.) or with SecYEG(ND) (B.). The increase of Bpy donor fluorescence due to the 
decrease in FRET was monitored.  
 
We continued the investigation of the conformational change of FtsY upon binding to 
SecYEG(ND). A a double cysteine mutant of full-length FtsY was constructed for 
measurements of homoFRET between two identical fluorophores. The same positions were 
used as in the previous experiments: V342C and A167C, and both positions were labeled with 
Bodipy FL (FtsY(167Bpy,342Bpy)). Bodipy FL has a small Stokes shift (Figure 3-11, panel A.), 
high extinction coefficient and the Förster distance for homoFRET is about 57 Å. This makes it 
suitable for the purpose of our measurements (Buskiewicz et al, 2005; Lakowicz, 2003; Runnels 
& Scarlata, 1995). In the homoFRET measurements, Bodipy FL is both donor and acceptor, and 






Figure 3-11 FtsY domain rearrangements upon binding toSecYEG(ND) or ND monitored by homoFRET.  
A. Bodipy FL (Bpy) excitation (dashe line) and emission (solid line) spectra, showing the small Stokes shift of 20 
nm. B.  Titration of 0.05 µM FtsY, labeled at positions 167 and 342 with Bpy, with SecYEG(ND) or with ND. The 
increase in anisotrpy was monitored due to the decrease in FRET. As a control we used single-labeled FtsY, at 
position 342 with Bpy, and titrated it with SecYEG(ND). 
 
We titrated FtsY(167Bpy,342Bpy) with SecYEG(ND) or ND and monitored the change in 
anisotropy (Figure 3-11, panel B.). In the titration with SecYEG(ND), the anisotropy of FtsY 
increased from 0.09 to 0.2. The increase in anisotropy indicated that the distance between the 
two fluorophores increased upon binding, thus the distance between the two FtsY domains 
also had increased. In the control titration with empty ND, no change of anisotropy was 
observed, indicating that binding to ND did not cause a change of the domain arrangement of 
double-labeled FtsY. In the control experiment where we used FtsY labeled only at position 342 
with Bodipy FL, the anisotropy remained at an initial value of 0.25. Given the different 
experimental setups, the Kd of FtsY binding to SecYEG(ND) was comparable with the values 
obtained in the titrations described above, i.e. 0.2 ± 0.01µM for FtsY(196Bpy) binding to 
SecY(111MDCC)EG(ND) or 1.2 ± 0.2 µM the binding of the complex of the two domains FtsY-
NG(342QSY9) and FtsY-A(167Bpy) to SecYEG(ND).  
3.3.3 The contribution of the individual domains of FtsY to the binding to 
SecYEG(ND) 
So far, we have shown that the dissociation of FtsY from SecYEG(ND) takes place in two steps. 
Also the separate domains of FtsY bind independently to SecYEG(ND). This suggested that 





examined the four domain variants of FtsY which we used previously: FtsY-A197, FtsY-A208, 
FtsY-NG and FtsY-NG+1 (Section 3.2.4.), for their ability to compete with full-length FtsY for 
binding to SecYEG(ND). Thus, we performed a series of competition titrations. In these 
experiments, we titrated SecY(111MDCC)EG(ND) with FtsY(196Bpy) in the presence of 
increasing concentrations of the FtsY domains.  
The four variants were added in concentrations up to 10 or 15 µM (Figure 3-12). Given 
affinities around 0.2 µM (Table 3-2), this concentration range should saturate any effect on 
FtsY binding. We observed that FtsY-NG+1, FtsY-NG and FtsY-A197 did not affect the affinity 
of full-length FtsY binding to SecYEG(ND). Only FtsY-A208 decreased the affinity. 
Additionally, FtsY-A208 caused a significant decrease of the fluorescence change of the donor 
and FtsY-A197 had a minor effect on the fluorescence signal. The two NG domain construct 
did not influence the fluorescence signal at all. These results indicated that FtsY-NG and FtsY-
NG+1 do not influence the binding of full-length FtsY, although they should be bound, given a 
binding affinity around 0.2 µM. On the other hand, the A-domain variants appear to alter the 
binding of FtsY(196Bpy). Especially, FtsY-A208 which decreased the fluorescence amplitude 
and the affinity of the interaction due to complex formation with SecYEG(ND). FtsY-A197 had 
a similar, somewhat smaller effect on the fluorescence amplitude.  
To quantitate the effect of competitors on the binding of FtsY to SecYEG(ND) the apparent 
Kds were plotted against the competitor concentration (Figure 3-12, panel F.). The data was 




𝐶 ∗ 𝐶 + 𝐾𝑑
𝐹, where 
𝐾𝑑𝑎𝑝𝑝 is the apparent affinity of FtsY and SecYEG(ND) in the presence of competitor, 𝐾𝑑
𝐹is 
their affinity in the absence of competitor, C is the competitor concentration, 𝐾𝑑
𝐶
 is the affinity 
of the competitor to SecYEG(ND) (Segel, 1993). From the analysis of the apparent Kds the 
intrinsic Kd of FtsY was calculated to be 0.2 – 0.3 µM, in agreement with the direct 
measurements; the Kd of FtsY-A208 was estimated to be 0.3 µM, also in agreement with direct 







Figure 3-12 Influence of FtsY-NG and A domains on FtsY binding to SecYEG(ND).   
SecY(111MDCC)EG(ND) was titrated with FtsY(196Bpy) in the presence of increasing concentrations of  
competitor: A. FtsY-NG, B.  FtsY-NG+1, C. FtsY-A208, D. FtsY-A197 or E. FtsY. F. Plot of the apparent affinities 
of FtsY(196Bpy) versus the concentration of competitor construct. 
 
3.4 Interaction of the ribosome with SecYEG(ND)  
In general the interaction between the Sec translocon and the ribosome has been well 
characterized. There are numerous structural studies (Becker et al, 2009; Beckmann et al, 1997; 
Frauenfeld et al, 2011; Gogala et al, 2014; Menetret et al, 2007) which were aiming at capturing 
different states of the translocon during protein translocation. In addition there are also 





correlation spectroscopy (FCS), that describe the interaction in thermodynamic terms 
(Behrens et al, 2013; Prinz et al, 2000; Wu et al, 2012). The later all converge to the same 
conclusion it is a high affinity interaction in the nanomolar range. Little is known on the 
interaction of the ribosome with SecYEG in the presence of FtsY. We wanted to investigate the 
interaction between SecYEG(ND) and the ribosome in the context of the other interaction 
partner FtsY. 
3.4.1 Affinity of the ribosome to SecYEG(ND) 
First we established a reporting system for the interaction between the ribosome and 
SecYEG(ND). We used a FRET reporter pair between the donor MDCC and the acceptor 
Alexa488 (Alx488). The ribosomal protein L23 protein was labeled with the donor fluorophore 
at position S21C (70S(L23MDCC)) and SecY was labeled with the acceptor at position S111C 
(SecY(111Alx488)EG(ND) (Holtkamp et al, 2012b). Based on cryo-EM structure we expected 
that the two labels will not interfere with each other and will be in a sufficient FRET distance 
(Figure 3-13, panel A.) (Frauenfeld et al, 2011). 
In equilibrium experiments we measured the affinity between the ribosome and SecYEG(ND). 
We used either vacant ribosomes (70S) or Lep75-RNC or Lep94-RNC (Figure 3-13, panel B). In 
the presence of the nascent chain the affinity of the ribosome to SecYEG(ND) increased 5 – 7-
fold, from 0.05 ± 0.02 µM to 0.010 ± 0.002 for Lep75-RNC and to 0.008 ± 0.003 µM for Lep94-
RNC. Our findings were in line with the published data that the interaction with RNC is 








Figure 3-13 Affinity of SecYEG(ND) binding to the ribosome.  
A. Reporter positions on the 70S at protein L23 labeled at position S21C with MDCC (yellow) and SecY labeled at 
position S111C with Alexa 488 (pink) ((Frauenfeld et al, 2011) PDB ID 3J00 and 3J01) B. Affinity titration of 
70S(MDCC), Lep75-RNC and Lep94-RNC with SecY(111MDCC)EG(ND).  
 
3.4.2 Dynamics of SecYEG(ND) complex formation with the ribosomes 
To examine in more detail the effect of the nascent chain on the interaction with SecYEG(ND) 
we performed a series of kinetic experiments. At first, we probed the complex formation by 
rapidly mixing MDCC-labeled 70S or Lep75-RNC or Lep94-RNC with increasing 
concentrations of SecY(111Alx488)EG(ND). The experiments we performed under pseudo-first-
order conditions with 0.016 µM ribosomes and an excess of SecYEG(ND) (0.09 to 0.2 µM). All 
stopped-flow traces could be fitted to a double exponential function (Figure 3-14, panels A –
C.). The apparent rate constants of the first step (kapp1) increased linearly with the 
SecYEG(ND) concentrations with a slope corresponding to the k1 = 110 ± 10 µM-1s-1 and y-
intercept corresponding to k-1 = 4 ± 1 s-1  (Figure 3-14, panel D.). The second step (kapp2) did not 
change systematically. (Figure 3-14, panel E.). In the concentration range used the kapp2 
appears to be already saturated at 0.1 µM. Taking into consideration k-2 (measured later in this 






Figure 3-14 Rapid kinetics of SecYEG(ND) complex formation with the ribosomes.  
SecYEG(ND) complex formation with A. 70S, B. Lep75-RNC and C. Lep94-RNC. MDCC-labeled 70S or RNC 
(0.016 µM final concentration) were titrated with Alx488- labeled SecYEG(ND). Complex formation was 
monitored by the increasing Alx488 fluorescence due to FRET. D. Concentration dependence of kapp1. E. 
Concentration dependence of kapp2. F. Two-step scheme of the interaction of SecYEG(ND) and the ribosome. 
 
These results indicated a two-step binding mechanism with a rapid first step, which is close to 
diffusion controlled and a second slow step. The calculated Kd of 0.03 ± 0.01 µM is similar to 
the Kd measured at equilibrium. 
Next we asked whether the nascent chain on the ribosome could have a stabilization effect on 
the complex with SecYEG(ND). We performed dissociation experiments where we pre-formed 
the complex of 0.016 µM 70S(L23MDCC) or Lep75-RNC/Lep94(L23MDCC) and 0.16 µM 
SecY(111Alx488)EG(ND) and rapidly mixed it with a 10-fold excess of vacant ribosomes (1.6 
µM). The stopped-flow traces were again fitted to a double exponential function (Figure 3-15). 
The rate of the first step (k-1) was similar for vacant ribosome and RNC, 3 ± 1 s-1. The second 





measurements, where the nascent chain enhanced the binding of the ribosome and 
SecYEG(ND), the kinetic measurements did not show any differences between the complexes. 
A possible explanation is that the affinity increase of 5 to 7-fold is too small to be seen in the 
kinetic experiments. 
 We concluded that the complex between SecYEG(ND) and the ribosome forms rapidly with a 
k1 in the same range as the targeting of the ribosome by SRP, but also is a short-lived complex 
with a half-life of 0.2 s. In comparison to the complex of FtsY and SecYEG(ND) it is 10-times 
less stable.  
 
Figure 3-15 Dissociation kinetics of the complex of SecYEG(ND) with the ribosomes.  
Complexes of SecY(111Alx488)EG(ND) and 70S(L23MDCC), Lep75-RNC(L23MDCC) or Lep94-RNC(L23MDCC) 
were pre-formed. Dissociation was induced by rapidly mixing the complexes with 10-fold excess of unlabeled 70S 
and the change in fluorescence of Alx488 was monitored. 
 
3.5 Interplay of FtsY and the ribosome  
In the course of targeting the translating ribosome, carrying a signal anchor sequence, is 
transferred from SRP to the SecYEG. Previous studies show that SRP and SecY have 
overlapping binding sites on the ribosome near protein L23 (Frauenfeld et al, 2011; Halic et al, 
2006b; Menetret et al, 2007) and the binding to SecY would interfere with the binding to SRP. 
Recently, it was has shown by using in vivo crosslinking techniques that FtsY and the 
ribosome also bind at similar sites on SecY (Kuhn et al, 2011). This raises the question whether 





To answer this question we used a fluorescence approach in combination with equilibrium and 
rapid kinetic techniques. First we performed a competition experiment between FtsY and the 
70S. The complex of SecY(111MDCC)EG(ND) and FtsY(196Bpy) was pre-formed and the 
labeled FtsY was displaced with a 10-fold excess of non-labeled competitor, 70S or FtsY, as a 
control. In both cases the shape of the dissociation traces was similar and we fitted them to 
exponential decay function (Figure 3-16). The apparent rate constants of both fits were in the 
same range (kapp-1 = 12 – 23 s-1, kapp-2 = 0.4 – 0.7 s-1, kapp-3 = 0.006 – 0.008 s-1). Thus, we 
confirmed the previous observations that the ribosome and FtsY can compete for binding to 
SecY. 
 
Figure 3-16 Dissociation of FtsY from SecYEG(ND) in competition with vacant ribosomes 
Complexes of SecY(111MDCC)EG(ND) and FtsY(196Bpy) were pre-formed. Dissociation was induced by rapidly 
mixing the complexes with a 10-fold excess of 70S or unlabeled FtsY and the change in fluorescence of Bpy was 
monitored. In black is the control trace showing that the complex is stable upon mixing with buffer. 
 
These experiments were performed in conditions where we add a large excess of competitor. In 
the cell, however processes are at steady-state and the concentration of FtsY is only 2 – 3-fold 
lower than of the ribosomes (Drew et al, 2003). Moreover not more than one third (20 – 30 % of 
all proteins are extracytosolic) of all ribosomes could be engaged in the synthesis of membrane 
proteins. In order to gain better understanding of the process, we performed competition 
experiments at equilibrium conditions. We titrated SecY(111MDCC)EG(ND) with 
FtsY(196Bpy) in the presence of increasing amounts of vacant ribosomes or RNCs carrying 






























LepB signal anchor sequence at position 4 – 22 (Figure 3-17). The Lep-RNC were prepared by 
in vitro translation of 3’-truncated Lep-mRNA (Bornemann et al, 2008). We chose RNCs with 
nascent chains of 75 and 94 amino acids. As 75 amino acids of Lep, of which about 40 are 
exposed outside the peptide exit tunnel, are sufficient to enter the SecY channel and 95 amino 
acids should be sufficient for the TM segment to be inserted into the lipid bilayer, forming a 
rather stable interaction (Ismail et al, 2012). 
In the presence of ribosomes or RNCs, FtsY binds to SecYEG(ND) with the same affinity (Kd ≈ 
0.2 µM) as in the control experiments where no ribosomes are present, but decreased the 
fluorescence amplitude. Such behavior is typical for noncompetitive binding, where the two 
ligands occupy different binding sites that do not influence each other, at least not in a way 
that would change the affinities. This result suggested that a ternary complex of FtsY, SecYEG 
and the ribosome can be formed.  
In the titrations the fluorescence change is dependent also on the concentration of ribosomes. 
By plotting the final fluorescence levels against the concentration of ribosomes we can obtain 
an apparent affinity of the ribosomes to SecYEG(ND) in the presence of FtsY (Figure 3-17, 






, where F is 
the  fluorescence level in the absence of ribosomes, FR is the fluorescence level in the presence 
of ribosomes, R is the concentration of the ribosomes in the titration, and 𝐾𝑑𝑎𝑝𝑝is the apparent 
Kd. The affinities obtained by this analysis were in line with the previous direct measurement 







Figure 3-17 Titration of SecY(111MDCC)EG(ND) with FtsY(196Bpy) in the presence of increasing 
amounts of ribosomes or RNCs. 
0.05 µM SecY(111MDCC)EG(ND)was titrated  with FtsY(196Bpy) in the presence of A. vacant ribosomes, or 
RNCs carrying different length of the signal anchor sequence of LepB: B. Lep75-RNC and C. Lep94-RNC. D. Plot 
of the final fluorescence levels change due to the presence of ribosomes against the ribosome concentration. 
 
3.6 The role of the FtsY A domain in the ternary complex with SecYEG(ND) 
and the ribosome  
So far we have demonstrated that FtsY and the ribosome can form a ternary complex with 
SecYEG(ND) (Section 3.5). Also we have shown that both NG and A domains of FtsY interact 
with SecYEG(ND). The A domain (FtsY-A208) appears to contribute to the stabilization of FtsY 
on SecYEG(ND) (Section 3.2). Next, we asked which domain of FtsY is important for formation 
of the ternary complex. Thus, we performed a series of equilibrium titrations of 
70S(L23MDCC) and SecY(111Alx488)EG(ND) in the presence of increasing concentrations of 
the different FtsY variants (Figure 3-18).  
In all titrations the presence of FtsY did not influence the affinity of the complex between the 





fluorescence amplitude decreased in the presence of FtsY, FtsY-A208 and partly by FtsY-NG+1 
(Figure 3-18, panels A., B. and D.). The other two constructs, FtsY-A197 and FtsY-NG (Figure 
3-18, panels C. and E.), had very little influence on the interaction. These results are in line 
with our previous observation that the ribosome and FtsY can interact simultaneously with 
SecYEG(ND) and do not influence each other’s binding affinities. Furthermore, the FtsY 
variants which affected the signal amplitude encompassed the critical MTS, which would 




Figure 3-18 FtsY effect on ribosome-SecYEG(ND) complex formation.  
Titration of 70S(MDCC) ribosome with SecY(111Alx488)EG(ND) in the presence of increasing concentrations of 






3.7 The contribution of the FtsY-A domain to the GTPase activation of FtsY 
and SRP 
Previous work of the GTPase activation of FtsY and SRP has shown that lipid vesicles 
containing anionic phospholipids increase the intrinsic activity of FtsY and also stimulate the 
activation of the SRP-FtsY complex (de Leeuw et al, 2000; Lam et al, 2010; Stjepanovic et al, 
2011b). So far, there has been no clear evidence on the effect of SecYEG on the GTPase 
activation of FtsY and the SRP-FtsY complex. We continued our investigation on the function 
of FtsY A domain, by testing its role in the GTPase activation of the complex between SRP, 
FtsY and SecYEG(ND). We compared FtsY to FtsY-NG and FtsY-NG+1 in three different 
approaches: (a) intrinsic GTPase activity; (b) activation of the SRP-FtsY complex; (c) activation 
of the SRP-FtsY complex in the presence of FtsY interaction partners SecYEG(ND) or ND. 
3.7.1 The intrinsic GTPase activity of FtsY 
First, we measured the intrinsic GTPase activity of FtsY, FtsY-NG and FtsY-NG+1. FtsY-NG 
and FtsY-NG+1 showed a 10 – 15 – fold lower catalytic activity (0.002 min-1) compared to the 
full-length protein (0.03 min-1) (Figure 3-19, panel A.). This suggested that the A domain is 
involved in the activity of FtsY. To test this possibility, we titrated the NG domain of FtsY with 
the A domain and compared the activity to the full-length protein (Figure 3-19, panel B.). We 
observed that at an equimolar ratio of FtsY-A208 to FtsY-NG the hydrolysis activity was 
stimulated to about 50% of the level of full-length FtsY. The stimulatory effect was not 
observed with the shorter A domain construct FtsY-A197. These results indicated that the A 
domain of FtsY and especially the MTS has a function in the intrinsic GTPase activity of FtsY, 
and is in keeping with the observation that the two domains associate in a high affinity 







Figure 3-19 Intrinsic GTPase activity of FtsY. 
We have measured GTP hydrolysis by FtsY, FtsY-NG+1 and FtsY-NG, A. NG domains. B. NG domains plus A 
domains.  
 
3.7.2 Activation of the GTP hydrolysis of the SRP-FtsY complex 
In order to characterize the GTPase activity of the activated complex of FtsY and SRP in the 
presence of SecYEG(ND) or ND we needed to make sure that GTP is present in saturating 
concentration. First, we measured the Km for GTP of the separate proteins and in complex 
(Figure 3-20).  
 
Figure 3-20 Titration of FtsY, SRP and the SRP-FtsY complex with GTP. 
Titration of A. 5 µM FtsY, B. 1 µM SRP. C. the complex of SRP and FtsY with increasing concentrations of GTP. 
 
FtsY alone showed a Km of 250 ± 100 µM, which is rather high in comparison to the 
physiological concentrations of GTP (200 – 500µM; (Traut, 1994)). Also its catalytic efficiency 





Accordingly, in complex with SRP the catalytic efficiency increased 1000 fold and also the Km 
increased 10 fold to 20 ± 15 µM (Table 3-4). This suggests that in the complex GTP is bound 
more strongly and that SRP appears to be an activator of FtsY. This is in line with previous 
crystallographic studies which indicate that SRP - FtsY complex forms a composite active site 
where the nucleotides are aligned and that a catalytic G (G83) nucleotide from the SRP RNA 
inserts into that active site to stimulate the hydrolysis (Ataide et al, 2011; Egea et al, 2004; 
Focia et al, 2004; Spanggord et al, 2005; Voigts-Hoffmann et al, 2013).  
In order to fulfill the requirement of multiple turnover hydrolysis based on the Km of 20 µM, in 
the following experiments we used a saturating concentration of 100 µM GTP. 
Table 3-4: Steady-state GTPase of FtsY, SRP, and FtsY/SRP  
GTPase Km, µM kcat, min-1 kcat/Km, µM-1*min-1 
FtsY 250 ± 100 0.13 ± 0.03 0.0005 
SRP 5.1 ± 0.5 4.5 ± 0.1 0.9 
SRP:FtsY 20 ± 15 10 ± 2 0.5 
 
To examine the effect of SecYEG(ND) and ND on the GTPase activity of the SRP:FtsY 
complex, we determined the Km of the binary complex of FtsY and SecYEG(ND) or ND. We 
used 5 µM FtsY and titrated SecYEG(ND) and ND from 0 to 22 µM. The Km for both 
SecYEG(ND) and ND was 6 ± 1 µM and the rate of the GTPase activity of FtsY increased to 2 – 







Figure 3-21 GTPase activity of FtsY bound to SecYEG(ND) or ND  
To examine whether the A domain of FtsY has an impact on the GTPase activation of the SRP – FtsY 
complex, 0.5 µM SRP was titrated with FtsY, FtsY-NG and FtsY-NG+1 with or without the addition of 12 
µM SecYEG(ND) or ND (Figure 2 – 22). We compared the rate constants of the different complexes ( 
Table 3-5) and found there was no significant difference in the GTPase activation between SRP in 
complex with FtsY, FtsY-NG+1 and FtsY-NG. Thus, the NG domain of FtsY appears to be sufficient to 
form the activated complex with SRP. In addition, the presence of SecYEG(ND) or ND did not have any 
effect on the Km or kcat of the complex of SRP and FtsY and its variants.  
Table 3-5 GTPase rate constants of the SRP complex with FtsY-NG domain variants in the presence of 
SecYEG(ND) and ND 






FtsY 8 ± 1 17 ± 1 2.1 
FtsY + ND 11 ± 3 24 ± 4 2.2 
FtsY + SecYEG(ND) 9 ± 3 19 ± 3 2.1 
FtsY-NG+1 9 ± 2 16 ± 1 1.8 
FtsY-NG+1 + ND 5 ± 1 17 ± 2 3.4 
FtsY-NG+1 + SecYEG(ND) 4 ± 1 12 ± 1 3.0 
FtsY-NG 18 ± 7 21 ± 5 1.2 
FtsY-NG + ND 11 ± 3 24 ± 4 2.2 







Figure 3-22 GTPase activity of the SRP complex with FtsY or FtsY-NG domain variants in the presence 
of SecYEG(ND) or ND. 
SRP (0.5 µM) in the presence of 100 µM GTP was titrated with increasing concentrations A.FtsY, B. FtsY-NG+1 








4.1 The interaction between FtsY and SecYEG 
According to the current understanding of SRP-dependent protein targeting, the translating 
ribosome is transferred to the SecYEG translocon assisted by SRP and its receptor, FtsY. The 
accuracy and timing of the process are achieved mainly via the early recognition of the N-
terminal SAS by SRP, followed by GTP-controlled interaction of SRP with FtsY, which also 
reflects the presence of proper SAS (Holtkamp et al, 2012b; von Loeffelholz et al, 2013). As 
accepted that the scanning and targeting of the ribosome occur in the cytoplasm, it is still 
speculated whether FtsY resides at the membrane or it shuttles between the membrane and 
the cytoplasm (Lam et al, 2010; Luirink et al, 1994; Mircheva et al, 2009; Parlitz et al, 2007). 
Recent results in vivo suggest that FtsY is largely present at the membrane, presumably bound 
to the SecYEG translocon (Mircheva et al, 2009). The present analysis in vitro confirms this 
observation. By performing equilibrium titration, monitored by FRET, we observe that FtsY 
binds to SecYEG inserted into nanodiscs (SecYEG(ND)) with 0.2 µM affinity. We have also 
verified the affinity using a label-free method, ITC. The kinetic stability of the complex 
assessed by dissociation kinetics revealed an overall half-life time of the complex of 1.7 s, 
which suggests a relatively stable complex. The finding is in agreement with previous 
observations that it is required for FtsY to be initially associated with the membrane, in order 
to guide the SRP-RNC complex to SecYEG and also to release SRP from the RNC (Mircheva et 
al, 2009). In our system the binding affinity of FtsY was independent of the presence of GTP or 
GTP analogs, whereas the binding of FtsY to inverted vesicles appeared to be enhanced in the 
presence of GTP (Angelini et al, 2006). Nevertheless, in the cell FtsY is more likely to be in 
complex with GTP, due to the fast nucleotide exchange rate and the high cellular 
concentration of GTP (Jagath et al, 1998; Traut, 1994). We did not observe complex formation 
of FtsY and SecYEG when SecYEG was solubilized in detergent. This observation may explain 
some controversies in the literature regarding the localization of FtsY and the role of SecYEG 
as GTPase activator (Akopian et al, 2013a; Shen et al, 2012). 
We have also examined the relative contribution of FtsY interaction with SecYEG and lipids to 
the overall complex stabilization, as it has been reported that FtsY is tethered to the 





phospholipids and the other with a proteinaceous factor, which later has been shown to be 
SecYEG (Angelini et al, 2005; Millman et al, 2001). Our results confirmed that FtsY binds 
equally well to SecYEG(ND) and to empty ND. Considering the cellular concentration of FtsY 
of about 17 µM and the affinity to SecYEG and lipids of 0.2 – 0.4 µM, then FtsY appears to be 
primarily membrane associated, either in complex with lipids or with the translocon (Kudva et 
al, 2013). 
Previous studies of the cellular localization of FtsY have reported that both the N-terminal A 
domain and the NG domain can associate with the membrane, suggesting two binding sites 
for FtsY (de Leeuw et al, 1997; Millman et al, 2001). In our dissociation kinetics we also 
observed a two-step dissociation of FtsY, which would be consistent with two binding sites. 
We tested this possibility using four domain variants of FtsY, two of the NG domain and two 
of the A domain. The two NG variants either encompassed the critical membrane targeting 
sequence (MTS), or not. The two A domain variants either encompassed two amphiphilic 
sequences, the N-terminal lipid binding sequence and the MTS, or only the N-terminal lipid 
binding sequence. Despite the substantial truncations and the ability or disability to bind 
lipids, all four constructs exhibited similar affinity to SecYEG(ND) as the full-length protein. 
Further, our analysis focused on the contribution of the separate domains to the membrane 
localization of FtsY. Interestingly only the A domain which encompasses both lipid-binding 
sequences was able to compete with FtsY, though to lesser extent than the full-length protein. 
From our data we could not exclude a partial competition model, where FtsY still could bind to 
SecYEG(ND) in the presence of the isolated A domain. This would mean that the full-length 
protein still could bind SecYEG (ND) via the NG domain, thus explaining the decrease of the 
final fluorescence, observed in our experiments. Even though the affinities to SecYEG(ND) 
were similar, the NG domain variants were not able to compete with the full-length protein 
for SecYEG(ND) binding. One possibility is that the NG domain in the full-length protein is 
more flexible and binds differently to SecYEG(ND) than the isolated NG domain. These results 
once more pointed out the important role of the MTS, this time for binding to SecYEG. 
Previous reports have shown that the MTS promotes lipid-binding of the NG domain (Bahari 
et al, 2007; Parlitz et al, 2007; Stjepanovic et al, 2011a). Whereas here we have demonstrated 
that as part of the A domain the MTS appears to stabilize FtsY on SecYEG(ND). In a complex 





interaction with the NG domain of SRP, while FtsY is bound to SecYEG, which would be 
consistent with the kinetic analysis (Holtkamp et al, 2012b).  
The observation that the separate FtsY domains each bind to SecYEG(ND) with similar 
affinities as the full-length FtsY posed an interesting question. A simple model in which the 
two domains make separate, equally strong contacts would predict that the full-length protein 
binds with the added affinities of the individual domains. However, this is not observed. One 
possibility to explain this behavior would be that in unbound form of FtsY there are binding 
interactions between the two domains which have to be disrupted in order to allow the 
binding to SecYEG. A similar model was reported previously for the M and NG domains of Ffh 
in SRP where domains form strong interactions which have to be disrupted upon SRP binding 
to the ribosome (Buskiewicz et al, 2005). In fact, when we examined whether there is complex 
formation between A and NG domains of FtsY we observed a complex of extremely high 
affinity, Kd = 9 nM. To examine whether the FtsY domains move apart upon binding to 
SecYEG(ND) we applied a homoFRET approach, using the same fluorophore, Bodipy FL, in the 
two domains. Our results revealed that the NG and the A domain are in close proximity in 
unbound FtsY in solution, but the binding to SecYEG(ND) is accompanied by a conformational 
rearrangement which increases the distance between the domains. The binding to empty ND 
did not result in any rearrangements.  
These results can be summarized in a model where the SRP receptor FtsY is mainly localized 
at the membrane, contacting both phospholipids and SecYEG. The conformation of FtsY is 
‘closed’ when FtsY interacts only with the lipids. In the case when FtsY binds to SecYEG the 
NG and A domain undergo a rearrangement and the two domains move apart, forming an 
‘open’ conformation. In this way the A domain may facilitate the stabilization at the SecYEG 
translocon and the NG domain is available for binding to SRP (Figure 3 – 1). Such a model 
would also explain previous reports where FtsY with truncated A domain is still functional in 
SRP binding and GTPase activation, but only partially rescues a ΔFtsY phenotype, probably 
since it is not bound stably enough at the SecYEG (Bahari et al, 2007; Eitan & Bibi, 2004). 
Furthermore, a closed conformation of FtsY, which is impaired in binding to SRP and needs to 
be activated for complex formation by binding to SecYEG, could also explain how FtsY, 







Figure 4-1 Model of FtsY binding to SecYEG  
FtsY in complex with the cytoplasmic membrane in closed conformation, where the NG domain (yellow-orange) 
and the A domain (red) are in close proximity. The main interaction sites are at the A domain: (1) the N-terminal 
lipid-binding sequence (amino acids 1 – 14), and (2) the membrane targeting sequence (MTS) at the interface 
between the A domain and the N domain (orange). Upon interaction with SecYEG (blue) FtsY undergoes domain 
rearrangements, where the N terminal amphiphilic sequence remains in complex with the lipids, the MTS and the 
NG domain interact with SecYEG. Thus, the A and NG domain move apart and FtsY adopts an open 
conformation.  
 
4.2 Interplay between FtsY and the ribosome at the SecYEG translocon  
In the course of ribosome targeting to the SecYEG translocon, after the transfer of the RNC to 
the translocon is completed, it remains unclear whether FtsY remains bound to the translocon 
or leaves the complex. Previous crosslinking studies have shown that FtsY interacts with the 
cytosolic loops C4 and C5 of SecY, which are the main binding partners for the ribosome as 
well. This implies that FtsY and the ribosome compete for binding to the translocon (Kuhn et 
al, 2011). Initially we probed whether the ribosome can induce dissociation of FtsY from 
SecYEG(ND) and confirmed that they could  compete. Nevertheless, our previous data showed 
that FtsY binds to SecYEG(ND) at two sites via the NG and the A domains. Also that the A 
domain stabilizes FtsY on SecYEG(ND). Thus, there is the possibility that FtsY remains bound 
to SecYEG(ND), though in a different conformation, when the ribosome is bound. We tested 
this hypothesis and observed that FtsY and the ribosome can bind simultaneously to 
SecYEG(ND) in a noncompetitive manner. Thus, confirming that FtsY participates in the 





Our further analysis showed that the NG domain or the A domain, both encompassing the 
MTS, were able to participate in the ternary complex. These data would explain the in vivo 
observation that the isolated NG domain which includes the MTS is able to rescue the ΔFtsY 
phenotype, at least partially. Provided that, the critical MTS is responsible for the localization 
and the isolated NG domain interacts with SRP to promote its release from the RNC (Eitan & 
Bibi, 2004; Parlitz et al, 2007; Spanggord et al, 2005). Nevertheless, the A domain appeared to 
bind more firmly than the NG domain. Thus, confirming our previous observation that the two 
lipid-binding sequence assure the membrane localization and the interaction with 
SecYEG(ND).  
Previously, the ribosome-SecYEG interaction was quantified by surface plasmon resonance 
(SPR) which has shown that the complex is of high affinity and that the nascent chain further 
strengthens the interaction (Wu et al, 2012). By performing equilibrium titrations, monitored 
by FRET, we obtained similar affinities for SecYEG(ND) binding to 70S ribosomes of 50 ± 20 
nM and to Lep-RNC of 9 ± 1 nM. The kinetic analysis showed that the ribosome and 
SecYEG(ND) associate in a two-step mechanism, with a fast diffusion-controlled binding step, 
followed by a slower rearrangement step. The overall stability of the complex appeared to be 
low, with half-life time of the complex of 0.2 s. A stabilization of the complex in the presence 
of the signal sequence we did not observe in the kinetics. Most probably a difference in Kd of 5 
– 7-fold is too small to be detected by kinetic measurements. 
So far our data have shown that the A domain of FtsY is essential for the stabilization of FtsY 
on SecYEG. This effect is achieved via two sequences located at the N and the C terminus of 
the A domain (Braig et al, 2009). There is evidence suggesting that lipid-association stimulates 
the intrinsic GTPase activity of FtsY (de Leeuw et al, 2000; Lam et al, 2010). However, it is 
unclear how SecYEG influences the GTPase activation of FtsY and the SRP-FtsY complex. The 
studies that had investigated this process either used SecYEG solubilized in detergent (DDM) 
or only liposomes (Akopian et al, 2013b; Lam et al, 2010; Shen et al, 2012). Especially the use of 
DDM appears problematic, as our results show that FtsY does not interact with SecYEG in the 
presence of DDM. The GTPase activation of FtsY by liposomes is rather high, more than 100-
fold, albeit at very high liposome concentration in the millimolar range (Lam et al, 2010(Lam et 





in 2 – 5 µM concentration, would be saturated also at micromollar concentration of liposomes.  
Perhaps the use of the detergent (Nikkol) in the reactions could have perturbed the system. In 
our hands, FtsY is activated 2-fold both by SecYEG(ND) and ND at much lower, micromolar, 
yet saturating concentrations, which are also in line with the measured affinities. We further 
analyzed the effect on the GTPase activation of the SRP-FtsY complex by the FtsY binding 
partners SecYEG(ND) or ND. The GTP hydrolysis rate of the SRP-FtsY complex remained 
unaffected by SecYEG(ND) or ND. Also the complex of SRP with only the NG domain of FtsY 
exhibited the same catalytic activity as the SRP-FtsY complex. These results were in 
agreement with previous observations that the NG domains of SRP and FtsY are sufficient for 
GTPase activation of the complex (Bahari et al, 2007; Egea et al, 2004; Eitan & Bibi, 2004; Focia 
et al, 2004). Taken together the data presented on the function of the N-terminal A domain of 
FtsY converges to the conclusion that this domain mainly stabilizes FtsY on the SecYEG, while 
the NG domain can bind SRP and hydrolyze GTP.  
The present investigation allow for a refinement of the model of the SRP targeting pathway, 
by providing details of the interaction between SecYEG and FtsY and elucidating the function 
of the NG and A domains of FtsY (Figure 4-2). According to the current understanding of the 
targeting process, SRP rapidly scans the ribosomes until it is stably bound to one that has the 
exit tunnel filled (about 35 amino acids). As in the bacterial system there is no SRP-induced 
elongation arrest, continued translation may lead to the emergence of a non-signal sequence, 
resulting in SRP rejection (Bornemann et al, 2008; Holtkamp et al, 2012b). Alternatively, the 
appearance of a signal-anchor sequence (SAS) leads to a rearrangement of SRP that exposes 
the NG domain and strongly stabilizes the complex. This way the SRP-RNC complex is ready 
to be targeted to the membrane. FtsY on the other hand is localized at the membrane in the 
vicinity of SecYEG. There it can bind to SRP via its NG domain, which is exposed in the FtsY-
translocon complex, while it remains associated to the SecYEG via the A-domain contacts. 
There is evidence that following FtsY binding to SRP, the NG-NG complex translocates to the 
distal end of the 4.5S RNA, which is possible due to the long linker between NG and M 







Figure 4-2 Model of SRP targeting pathway  
SRP scans the translating ribosomes (RNC) for an emerging nascent chain.  In case that the nascent chain 
exposes a N-terminal signal anchor sequence (SAS) of a membrane protein, SRP rearranges and binds both the 
ribosome and the SAS. Like that the RNC-SRP complex is ready for targeting to the membrane. FtsY is localized 
at the membrane in the vicinity of the SecYEG translocon. Upon interaction with SecYEG, FtsY adopts an open 
conformation, which allows the NG domain (yellow-orange) to interact with the NG domain of SRP (green). Due 
to the high affinity between the RNC and SecYEG and the increased affinity of SRP and FtsY, the complex of 
RNC-SRP is targeted to the SecYEG-FtsY complex to the membrane. There in a GTP-dependent manner FtsY and 
SRP form a complex via their NG domains. The RNC is transferred to SecYEG and SRP is released from the 
quaternary complex after GTP hydrolysis. FtsY remains bound to SecYEG, though in a different conformation. 
 
Thus, upon initial targeting a quaternary complex is formed, and we speculate that this 
complex is transient, because the high affinity between RNC and SecYEG will probably lead to 
RNC transfer to the translocon, and competition between translocon and SRP for binding to 
overlapping sites at the peptide exit of the ribosome. Concomitantly with the rearrangement, 





SRP also releases the SAS. During the nascent chain translocation FtsY remains bound to 
SecYEG via the A domain while the NG domain remains in conformation that does not 
interfere with the ribosomal binding. In this state FtsY awaits the next round of targeting. 
 
  




5. Materials and Methods  
5.1 Equipment 
Table 5-1 List of equipment 
Device  Manufacturer  
Benchtop centrifuge 5415R and 5810R Eppendorf 
Centrifuge Avanti J-26 XP Beckmann Coulter 
Ultracentrifuge Optima L-100 XP Beckmann Coulter 
Ultracentrifuge Max-XP Beckmann Coulter 
Galaxy mini star centrifuge VWR 
Vortex Genie 2 Scientific Industries 
PCR thermocycler Peqstar Peqlab Biotechnologie  
Mini gel electrophoresis chamber Peqlab Biotechnologie 
Electrophoresis power supply EV261 Peqlab Biotechnologie 
Semi-dry blotter Peqlab Biotechnologie 
Water bath RE104 and E100  Lauda 
Nanodrop 2000C Peqlab Biotechnologie 
Milli-Q Advantage A10 Millipore 
Plates incubator INE600 Memmert 
Incubator shaker series Innova44 New Brunswick 
Fermenter – Biostat B Plus Sartorius Stedium Biotech 
ӒKTA FPLC GE Healthcare 
ӒKTA Explorer GE Healthcare 
Emulsiflex C-3 homogenizer Avestin 
Fluorolog spectrofluorometer Horiba Jobin Yvon 
FluoroMax-4 Horiba Jobin Yvon 
Fluorescence cuvette QS 750 µl Hellma Analytics 
FLA-7000 biomolecular imager Fuji 
Bio-vision imaging system Peqlab Biotechnologie 
Stopped-flow SX20D spectrometer Applied photophysics 
Fluorescence cut-off filters Schott AG 
Micro calorimeter iTC200 MicroCal 
Liquid scintillation counter PerkinElmer 
pH meter inoLAB 
pH electrode Sentix81 
 





Table 5-2 List of software 
Software Provider 
MultiGauge 2.0 Fujifilm 
FluorEssence 3.5 Horiba Scientific 
Pro-Data software suit Applied Photophysics 
Pymol 1.3 Schrödinger 
GraphPad Prism 5.0 GraphPad software 
Origin 7.0 OriginLab 
TableCurve 2D Systat Software 
MaxQuant 1.4.1.2 MaxQuant (Cox & Mann, 2008) 
 
5.3 Chemicals and consumables 
Chemicals were purchased from Sigma, Merck or Roth (Germany), unless stated otherwise. 
The chemicals for electrophoresis: agarose, acrylamide, SDS, were purchased from Serva; DTT 
and L(+)-Rhamnose monohydrate – Applichem; Complete protease inhibitor – Roche; 
GMPPNP, GTP and GDP – Jena Bioscience; yeast extract and tryptone – BD; kits for DNA 
preparation and TLC plates (Polygram PEI 300) – Macherey-Nagel; protein concentrators, 
nitrocellulose filters, sterile filters – Sartorius; Bio-Beads SM2 Adsorbent – Biorad; DNA 
oligonucleotides for mutagenesis – IBA Life Sciences, or Eurofins MWG Operon; Phusion DNA 
polymerase kit – New England Biolabs; FPLC columns and chromatographic resins – GE 
Healthcare; Ni-IDA resin – IBA Life Sciences; precision cells (Quartz SUPRASIL®) – Hellma 
Analytics; fluorescent dyes – Molecular Probes, Life Technologies; scintillation liquid IRGA-
SAFE Plus – PerkinElmer, Quickszint 361 – Zinsser Analytics; radioactive compounds – Perkin 
Elmer; [γ-32P]-GTP – Hartmann Analytic. 
 
 
5.4 Plasmids and strains 
Table 5-3: List of plasmids 




Plasmid name Product Promotor Tag Resistance Source 
pTRC99aSecYEG SecYEG trc 
SecE-N term 
His6 
Ampicillin C. Schaffitzel 
pET9a-FtsY FtsY wt T7 C term His6 Kanamycin J. Luirink 
pT-NG+1 FtsY-NG+1 T7 C term His6 Ampicillin E. Bibi 
pT-NG FtsY-NG T7 C tern His6 Ampicillin E. Bibi 
pSUMO-FtsY FtsY T7 N term His6 Kanamycin this work 
pSUMO-FtsY197 FtsY-A197 T7 N term His6 Kanamycin this work 
pSUMO-FtsY208 FtsY-A208 T7 N term His6 Kanamycin this work 
pET24-Ffh Ffh wt T7 C term His6 Kanamycin J. Jagath 
pMSP1D1 MSP1D1 T7 N term His7 Kanamycin Addgene 
pMSPE1D1 MSPE1D1 T7 N term His7 Kanamycin Addgene 
pT7-4.5S 4.5S RNA T7  Ampicillin G. Lentzen 
 
Table 5-4: List of bacterial strains 
Strain Genotype Application Source  
DH5α 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR 
nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169, 
hsdR17(rK- mK+), λ– 
Plasmid 
amplification 
In house  
BL21(DE3) F
– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
MSP expression In house 
BL21(DE3)pLys F
- ompT gal dcm lon hsdSB(rB- mB-) λ(DE3) 
pLysS(cmR) 




fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS/ 
pLemo(CamR) 
 λ DE3 = λ sBamHIo ∆EcoRI-
B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 














Table 5-5 List of primers 
Primer Sequence 5’ – 3’  
4.5S RNA  
sense        GGGTGGGGGCCCTGCCAGCTAC 
anti-sense CTTTATGCTTCCGGCTCGTATGTTGTGTGG 
SecY(S111C)  
sense       TAAGAAAGAAGGGGAGTGCGGTCGTCGTAAG 
anti-sense CTTACGACGACCGCACTCCCCTTCTTTCTTA 
FtsY(F196C)  
sense        CAAAGAAGGTTTTTGTGCGCGCCTGAAAC 
anti-sense GTTTCAGGCGCGCACAAAAACCTTCTTTG 
FtsY(A167C) 
sense        GCGGCAGAAGAGTGTGTGATGGTGGTTCC 
anti-sense GGAACCACCATCACACACTCTTCTGCCGC 
FtsY(V342C)  
sense        CGGTTGAACAGCTTCAGTGTTGGGGTCAGCGC 





FtsY cloning in 
pSUMO  
sense  GAACAGATTGGTGGTATGGCGAAAGAAAAAAAACG 
 anti-sense GTTAGCAGCCGGATCTTAATCCTCTCGGGC 
FtsY-A197  
sense        CAAAGAAGGTTTTTTCTAACGCCTGAAACGC 
anti- sense GCGTTTCAGGCGTTAGAAAAAACCTTCTTTG 
FtsY-A208 
sense        CGCAGCCTGTTAAAAACCAAATAATAGCTCGGTTC 
anti-sense GAACCGAGCTATTATTTGGTTTTTAACAGGCTGCG 
 
5.5 Site-directed mutagenesis 
Site-directed mutagenesis was performed with Phusion polymerase. Each reaction was 
performed in high fidelity buffer at final volume of 50 µl: 30 ng DNA template, 15 pmol from 
each primer, 15 nmol from each dNTP and 2 units Phusion polymerase. A typical PCR 
program starts with 3 min 95oC denaturation, followed by 25 cycles of 1 min 95oC 
denaturation, 35 sec. annealing at usually 55oC, followed by 30sec/kb elongation step at 72oC. 
In the last step after all products were elongated for 5 min at 72oC and finally stored at 4oC. 
Afterwards the template DNA was digested with DpnI restriction enzyme (New England 
Biolabs) for 1 h at 37 oC with 1 U/µg template DNA and later transformed to DH5α cells.  
 




5.6 Transformation  
For plasmid transformations CaCl2 chemically competent cells we used. To 50 µl of competent 
cells 60 ng of purified plasmid was transformed or 5 µl of PCR reaction. The cells were 
incubated for 15 min on ice and transformation was induced by 40 sec heat shock at 42oC, 
followed by 2 min incubation on ice. The cells were recovered for 1 h in 700 µl LB at 37oC. 
Afterwards the cells were collected by 2 min centrifugation at 5000 rpm in a benchtop 
centrifuge, resuspended in 200 µl LB and plated on LB-agar plates supplemented with the 
corresponding resistance antibiotic. 
5.7 4.5S RNA preparation 
The linearized DNA template for 4.5S RNA transcription was amplified in 1 ml PCR reaction 
volume. pT7-4.5S plasmid was used as template in combination with 4.5S RNA primers. The 
PCR had 40 cycles of amplification with an annealing temperature of 57oC. The resulting 
product was transcribed for 3 h at 37oC in 30 ml transcription buffer supplemented with 10 
mM DTT, 3 mM NTP-mix, 5 mM GMP, 150 µM T7 polymerase (home-made) and 3 U inorganic 
pyrophosphatese (IPP). The RNA was purified using a 5 ml HiTrap Q column with washing 
buffer RNA-BA and was eluted with a 20 CV gradient of buffer RNA-BB. The fractions of the 
RNA peak were collected and the RNA was ethanol precipitated by addition of 1:10 volumes 20 
% w/v potassium acetate and 2 volumes 100% ethanol. The precipitation was carried out over 
night at -20oC, followed by 1 h centrifugation at at 4oC, 4 rpm in a benchtop centrifuge. The 
resulting pellet was washed with 70 % ethanol and centrifuged for 30 min at 4oC, dried and 
resuspended in water. The concentration of the RNA was measured by absorption in water at 




4.5S RNA extinction coefficient = 1.0821 M-1cm-1.  
5.8 Protein expression and purification 
5.8.1 SecYEG 
SecYEG was overexpressed in E.coli strain Lemo21(DE3) (see Table 1 and 2 for details on 
plasmids and strains). Test expression yield positive clones that were kept as 40% glycerol 
stocks at -80o C. A large scale overexpression culture (6 L of LB) was inoculated with 200 ml 
overnight culture, supplemented with 100 µg/ml ampicillin, 30 µg/ml chloramphenicol and 800 




µM L-rhamnose and 3 drops of Antifoam 204™. The cells were grown at 37o C and induced at 
OD600 ~ 0.6 – 0.7 with 400 µM IPTG for 4 hours. Afterwards the cells were collected for 20 min 
at 5000 rpm in a Beckmann JLA.8.1000 rotor, washed once with buffer SecRB and shock frozen 
in liquid nitrogen. The usual pellet weight was 12 g. 
All further purification steps were carried out at 4o C. The pellet was thawed on ice and 30 ml 
opening buffer was added supplemented with 1 tablet of EDTA Free Complete protease 
inhibitor, lysozyme and one crystal of DNase. The cells were opened in one cycle in the 
EmusiFlex-C3 at 1.5 bar applied pressure and 1000 bar effective pressure. The debris was 
decanted for 20 min at 30000 x g in a JA 25.50 Beckmann rotor. The membranes were 
separated from the supernatant for 2 hours at 150000 x g in a Ti 50.2 Beckmann rotor. The 
collected membranes were resuspended in a 7 ml mortar and solubilized in 100 ml SecSB + 1 % 
DDM for 1 hour at 4oC with gentle agitation. The non-solubilized fraction was decanted for 30 
min at 75000 x g in a Ti 50.2 Beckmann rotor. The resulting supernatant was loaded onto a 5 
ml HisTrap column equilibrated with 5 CV buffer SecNiA. 
To avoid overloading of the HisTrap column the sample was loaded in two equal portions. 
After each loading a complete purification protocol was applied: 5 CV wash with SecNiA and 
eluted with 5 CV of buffer SecNiB. 
The two elution peaks were collected, concentrated to 2 ml in a 20 ml Vivaspin™ (Sartorius) 
with 10 kDa cutoff. The concentrated sample was rebuffered in SecSPA on a PD-10 (G25) 
column (GE Healthcare). Both samples were pooled and loaded on a 5 ml QTrap™ (GE 
Healthcare), equilibrated with 5 ml SecSPA. The column was washed with 5 CV SecSPA. 
SecYEG was eluted with a 8 CV linear gradient from 0 – 100 % SecSPB with a 2 CV gradient 
delay. The peak at 60 % was collected, concentrated and rebuffered to BufferA + 0.03 % DDM 
on a PD-10 (G25) column. Samples were collected from all purification steps and analyzed on a 
15 % SDS PAGE and Western blot. 
Protein concentration was calculated from the absorbance measured at 205 nm in H20 using 










FtsY was previously cloned in a pET9a vector and overexpressed in BL21 (DE3) pLys cells. A 
200 ml overnight culture (previously tested for overexpression) was used to inoculate 6 L of LB 
supplemented with 30 µg/ml kanamycin and 30 µg/ml chloramphenicol. At OD600 0.7 -0.8 the 
bacteria were induced with 1 mM IPTG for 2 hours. The cells were collected for 20 min at 5000 
rpm in a Beckmann JLA 8.1000 rotor, washed with FtsY-QSA and shock-frozen in liquid 
nitrogen.  
In the first purification step the cleared lysate of FtsY is loaded on 42 ml Q-Sepharose column. 
Typically 15 to 20 g of cell pellet were resuspended in 50 ml FtsY-QSA buffer supplemented 
with 2 pills of EDTA Free Complete protease inhibitor (Roche), lysozyme (Sigma) and one 
crystal of DNase. The cells were opened in one cycle in the EmusiFlex at 1.5 bar applied 
pressure and 1000 bar effective pressure. The debris was decanted for 45 min at 25000 rpm in a 
JA 25.50 Beckmann rotor. Then the cleared lysate was loaded on the Q-Sepharose column, 
equilibrated with FtsY-QSA. The unspecifically bound proteins were washed off with FtsY-
QSA, and FtsY was eluted with a linear gradient of 20 CV from 0-100 % FtsY-QSB. The peak 
containing FtsY was collected and loaded on 10 ml NiNTA (Qiagen) gravity flow column, 
equilibrated with FtsY-NiA. The resin was washed with 5 bed volumes (BV) FtsY-NiA, then 
with 5 BV FtsY-NiB, 3 BV FtsY-NiA and FtsY was eluted with 3 BV NiC. The elution was 
collected and dialyzed against 4 x 500 ml FtsY-QTA. Afterwards the sample was loaded on 5 ml 
HiTrap-Q column, equilibrated with FtsY-QTA. The unspecifically bound proteins were 
washed off with 5 CV FtsY-QTA and FtsY was eluted with a 20 CV linear gradient from 0 – 100 
% FtsY-QTB. The peak containing FtsY was collected concentrated to 3 ml in Vivaspin™ with 
cutoff 30 kDa and dialyzed against 2 x 500 ml BufferA. 
FtsY-NG+1 and FtsY-NG were expressed and purified in the same way as full-length FtsY, 
with minor amendments. The cells were resuspended in 20 ml FtsY-NiA supplemented with 1 
pill of EDTA Free Complete protease inhibitor (Roche), lysozyme (Sigma) and one crystal of 
DNase. The cells were opened in one cycle in the EmusiFlex at 1.5 bar applied pressure and 
1000 bar effective pressure. The debris was decanted for 45 min at 25000 rpm in a JA 25.50 
Beckmann rotor. Then the cleared lysate was loaded on 5 ml HisTrap column, washed with 5 
CV FtsY-NiB buffer supplemented with 0.01 % Nikkol. Then 5 CV FtsY-NiA buffer and finally 




eluted with 5 CV FtsY-NiC buffer. The elution was collected and dialyzed against 4 x 500 ml 
Ffh-QTA. Afterwards the sample was loaded on 5 ml HiTrap-SP column, equilibrated with Ffh-
QTA. The unspecifically bound proteins were washed off with 5 CV Ffh-QTA and FtsY was 
eluted with a 20 CV linear gradient from 0 – 100 % Ffh-QTB. The peak containing FtsY was 
collected concentrated to 3 ml in Vivaspin™ with cutoff 10 kDa and dialyzed against 2 x 500 
ml BufferA. 
FtsY-A197 and FtsY-A208 were expressed and purified in the same way as full-length FtsY, 
with minor amendments. The cell pellet was resuspended in 20 ml FtsY-NiA supplemented 
with 1 pill of EDTA Free Complete protease inhibitor (Roche), lysozyme (Sigma) and one 
crystal of DNase. The cells were opened in one cycle in the EmusiFlex at 1.5 bar applied 
pressure and 1000 bar effective pressure. The debris was decanted for 45 min at 25000 rpm in a 
JA 25.50 Beckmann rotor. Then the cleared lysate was loaded on 5 ml HisTrap column, washed 
with 5 CV FtsY-NiB buffer supplemented with 0.01 % Nikkol. Then 5 CV FtsY-NiA buffer and 
finally eluted with 5 CV FtsY-NiC buffer. The elution was collected and dialyzed against 4 x 
500 ml FtsY-QTA. Then the protein was concentrated to 100 µM in a Vivaspin with a cutoff of 
10 kDa and incubated overnight at 4°C with Ulp1 SUMO-protease 1:100 ratio of protease:FtsY-
A. Afterwards the sample was loaded on 5 ml HiTrap-Q column, equilibrated with FtsY-QTA. 
The unspecifically bound proteins were washed off with 5 CV FtsY-QTA and FtsY was eluted 
with a 20 CV linear gradient from 0 – 100 % FtsY-QTB. The peak containing FtsY was collected 
and incubated for 15 min with 4 ml of NiNTA equilibrated with BufferA. The flowthrough was 
collected and concentrated to 3 ml in Vivaspin™ with cutoff 10 kDa and dialyzed against 2 x 
500 ml BufferA. 
The concentration of FtsY was calculated by from the absorbance measured at 205 nm in 
water by the same equation as in section 4.8.1, where the molecular weight of FtsY is 50 kDa, 
FtsY-NG+1 and NG – 33 kDa, FtsY-A208 – 23 kDa and FtsY-A197 – 22 kDa. . 
 
5.8.3 Ffh 
pET24-Ffh vector was used to overexpress Ffh in E.coli BL21(DE3) pLys.   A 200 ml overnight 
culture (previously tested for overexpression) was used to inoculate 6 L of LB supplemented 




with 1 % glucose, 30 µg/ml kanamycin and 30 µg/ml chloramphenicol. At OD600 0.7 -0.8 the 
bacteria were induced with 5 mM IPTG for 2 hours. The cells were collected for 20 min at 5000 
rpm in a Beckmann JLA 8.1000 rotor, washed with Ffh-NiA and shock-frozen in liquid 
nitrogen. The usual pellet weight was 10 – 12 g. 
For the first step of purification the cell pellet was resuspended in 20 ml FfhNiA supplemented 
with 1 pill EDTA Free Complete protease inhibitor (Roche), lysozyme (Sigma) and one crystal 
of DNase. The cells were opened in one cycle in the EmusiFlex-C3 at 1.5 bar applied pressure 
and 1000 bar effective pressure. The debris was decanted for 45 min at 25000 rpm in a JA 25.50 
Beckmann rotor. The cleared lysate was loaded on a 5 ml HisTrap column, equilibrated with 
FfhNiA. The unbound sample was washed off with 10 CV FfhNiA and Ffh was eluted with 4 
CV FfhNiB. The 20 ml eluate was diluted 10 times with buffer FfhSPA and loaded on HiTrap 
SP HP 5 ml column. The unbound sample was washed off with 10 CV FfhSPA and Ffh was 
eluted withlinear gradient of 20 CV from 0 – 100 % FfhSPB. The peak containing Ffh was 
collected concentrated to 3 ml in a Vivaspin™ with cutoff 30 kDa and dialyzed two times 
against 500 ml BufferA. 
The concentration of Ffh was calculated by from the absorbance measured at 205 nm in water 
by the same equation as in section 4.8.1, where the MW of Ffh is 54 kDa. 
 
5.8.4 MSP 
MSP1D1 and MSPE1D1 were overexpressed in BL21(DE3) cells in a fermenter with LB media 
supplemented with 30 µg/ml kanamycin and induced at OD600 0.6 with 1 mM IPTG for 2 h.  
For the purification 7 -10 g of cells were resuspended in 20 ml MSP-B1 buffer supplemented 
with 2 pills of EDTA Free Complete protease inhibitor (Roche), lysozyme, one crystal of DNase. 
The cells were opened in one cycle in the EmusiFlex-C3 at 1.5 bar applied pressure and 1000 
bar effective pressure. The volume was brought to 80 ml with MSP-B1 and the debris was 
decanted in Beckmann Avanti centrifuge for 30 min 30000 rpm, 4°C in JA25.30 rotor. The 
cleared lysate was adjusted to 0.5 M NaCl and loaded on a 7 ml self-packed Ni-IDA column 
equilibrated with buffer MSP-B2. The column was washed with 4 CV MSP-B2, followed by 6 
CV MSP-B3, 6 CV MSP-B4, 3 CV 5% MSP-B5 and finally the protein was eluted with 100 % 




MSP-B5. The purity of the protein was verified by 15 % SDS-PAGE to be > 95%. The peak of 
MSP was collected concentrated to 5 ml in a Vivaspin with a cutoff of 10 kDa and dialyzed 
three times against 500 ml BufferA. 
The concentration of FtsY was calculated by from the absorbance measured at 205 nm in 
water by the same equation as in section 4.8.1, where the MW of MSP1D1 is 22 kDa and 
MSPE1D1 is 24 kDa. 
5.8.5 Fluorescence labeling of proteins 
All proteins were labeled according to the Invitrogen© recommendations for maleimide-thiol 
coupling reactions. The labeling buffer is described in Table 4 - 6 with slight modifications 
depending on the protein: for Ffh the buffer contained 300 mM KCl; for SecYEG the buffer 
contained 0.03 % DDM. The dyes were dissolved in DMSO to concentration of 20 mM. The 
protein and the dye were mixed in 1:5 ratios and incubated at room temperature for 2 hours 
with gentle agitation. The reaction was quenched with 10 mM DDT, diluted to 2.5 ml with 
BufferA and applied on a PD-10 (G25) desalting column. The 3.5 ml eluate was concentrated 
and the concentration of protein was measured at A205 and the concentration of the dye was 
measured at the respective absorption wavelength and calculated according to the extinction 
coefficient. The ration of the dye:protein concentration was taken as the efficiency of the 
labeling procedure. In case of residual dye the protein was dialyzed overnight in BufferA.  
5.9 Gel electrophoresis and blotting 
5.9.1 Soldium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
To analyse the proteins, SDS-polyacrylamide gels were used. The usual acrylamide 
concentration was 12 or 15 % (acrylamide/Bis solution29:1). Gels were prepared and ran 
vertically in SDS-PAGE running buffer. SDS-PAGE was basically performed as described 
previously (Laemmli, 1970; Weber et al, 1972). 
5.9.2 Clear native polyacrylamide gel electrophoresis (CN-PAGE) 
To analyze nanodisc complexes clear native polyacrylamide gel electrophoresis was performed. 
We used pre-casted gradient gels (4-20% acrylamide), according to the manufacturer’s 
instruction – Serva Electophoresis. In brief the samples were prepared in 2 X clear native PAGE 




samples buffer and loaded on the gel. The electrophoresis was performed in two step 15 min 
50V, followed by 2h at 200 V and the chamber was cooled to 10oC using a water bath.   
5.9.3 Native polyacrylamide gel electrophoresis 
SRP and SRP-FtsY complex formation was monitored on nondenaturating 7% polyacrylamide 
gel electrophoresis (acrylamide/Bis solution 19:1) (Jagath et al, 2000). The 4.5S RNA, Ffh and 
FtsY were incubated in BufferA + 25% glycerol in the presence of 0.2 mM GMPPNP for 5 min 
at 25oC before loading on the gel. The electrophoresis was performed in 1x gel-shift running 
buffer, supplemented with 5 µM GMPPNP, for 3 h at 80 V, at 10oC (the chamber was cooled by 
a waterbath). 
5.9.4 Denaturating polyacrylamide gel electrophoresis 
To check the quality of the RNA preparation, denaturating urea PAGE with 12 % 
polyacrylamide (19:1) was used. 10 ml of urea PAGE solution was polymerized by adding 100 
µM APS and 10 µM TEMED. The gel was pre-ran for 15 min at 20 Watts. The samples were 
prepared with formamide loading dye. The gel was ran in 0.5 x TBE buffer, on a water bath at 
50oC at 20 Volts until the dye reached the end of the gel. The gel was fixed for 10 min in 10 % 
v/v acetic acid and stained with methylene blue. Destaining was performed in water for 30 
min. 
5.9.5 Western blot 
To visualize the expression of SecYEG we used western blot against the His6-tag of SecE. The 
blotting procedure was performed in a semi-dry chamber according to the manufacturer’s 
instructions – PeqLab. The blotted membrane was immobilized with 20 % skim milk solution 
in 1x PBST buffer overnight at 4oC. Afterwards the membrane was washed 3 – 4x with PBST 
and incubated with for 2 h at room temperature with the primary anti-body (Anti-6x-His 
Epitope tag purchased from Thermo Fischer) diluted 1:1000 in 5 % skim milk in 1x PBST. To 
prepare the blot for the secondary anti-body the membrane was washed 3 – 4 x with PBST. It 
was then incubated for another 2 h with the secondary anti-body (Peroxidase-conjugated anti-
rabbit IgG, purchased from Dianova), horseradish peroxidase conjugated anti-body (1:10000 
dilution in 5% skim milk in PBST). Finally the membrane was thoroughly washed with PBST 
and incubated with the chemiluminescent substrate (Thermo Fisher) for several minutes 
before exposing on a chemiluminiscence film and developed it. 




5.10 Nanodisc preparation  
5.10.1 Lipids preparation 
In a round-bottom glass vessel 1 ml total E.coli lipid extract was pipetted. The chlorophorm 
solvent was evaporated under a nitrogen stream and the lipids were carefully layered on the 
walls of the vessel. Next, the dried lipids were placed in desiccator overnight. Then, the lipids 
were resuspended in 800 ml of H2O at 37o C for 2 hours with gentle agitation. Afterwards the 
lipids solution was collected and solubilized by addition of 10 % DDM. When the solution 
turned permanently clear at room temperature it was buffered with 0.5 M Hepes pH 7.5. The 
lipids were aliquoted and kept at -20o C. 
5.10.2 Nanodiscs assembly and purification 
The nanodiscs were formed overnight. For SecYEG in nanodiscs ratio of 1:2:30, 
SecYEG:MSP:lipids was used. For empty nanodiscs a ratio of 1:100 MSP:lipids was used. The 
samples were brought to total volume of the reaction of 400 µl by BufferA. After the 
components were mixed together the reaction was incubated on ice for 1 hour. In the 
meantime the BioBeads™ were soaked and equilibrated in BufferA. Firstly, approximately 0.5 
ml of beads were added in an 1.5 ml eppendorf tube and washed 3 times with 1 ml 100 % 
Methanol, followed by 3 x 1 ml H2O and 3 x 1 ml BufferA. The beads were drained from the 
excess buffer and the equivalent of 50 µl was added to each nanodiscs reaction. These were 
incubated overnight at 4o C with gentle agitation. Next, the beads were decanted and the 
reactions were transferred into new tubes, centrifuged for 5 min at 16 000 rpm in a bench top 
centrifuge and loaded on a self-packed Superdex 200 column (170 ml CV). The peaks 
containing nanodiscs were collected and concentrated in Vivaspin™ with cut-off 100 kDa for 
SecYEG(ND) or 30 kDa for ND. 
5.11 Mass spectrometry sample preparation 
Nanodisc samples were resolved on a clear native PAGE (in triplicates) and the bands of 
interest were excised. After in-gel trypsin digest the peptides extracted as previously described 
(Shevchenko et al, 1996). The tryptic fragments were analyzed in a LC-coupled ESI Q-ToF 
(QToF Ultima) and/or in an orbitrap (LTQ-Orbitrap XL) mass spectrometer under standard 
conditions. Raw data were processed by MaxQuant for peptide/protein identification and 




intensity base absolute quantification (iBAQ) (Smits et al, 2013). The sample digest and mass-
spectrometry analysis were performed by Monika Raabe and the data analysis by Ilian 
Atanassov at the group of Prof. Hening Urlaub, Bioanalytical Mass Spectroscopy, Max Planck 
Institute of Biophysical Chemistry, Göttingen.  
5.12 Negative staining for electron microscopy  
Serial dilutions of SecYEG(ND) were prepared in the range 2 – 0.02 µM in BufferA. The sample 
particles were absorbed on a mica carbon film, which afterwards was adhered on a copper 
grid, leaving the adsorbed particles on the solvent exposed side. The particles were stained for 
1 min in uranyl formate solution and visualized on a CM200 electron microscope, Philips. The 
negative-stain EM was performed by Andruis Krasauskas at the group of Prof. Holger Stark, 
3D Electron Cryo-Microscopy, Max Planck Institute of Biophysical Chemistry, Göttingen. 
5.13 Ribosomal nascent chain complexes preparation 
Ribosomes from E.coli MRE600, initiation factors (IF1,IF2 and IF3), EF-TU, EG-G, f[3H]Met-
tRNAfMet and totat tRNA were prepared as described (Rodnina & Wintermeyer, 1995). RNCs 
were prepared by in vitro transcription of mRNAs with truncated coding sequence, as 
described previously (Bornemann et al, 2008; Rodnina & Wintermeyer, 1995). About 80-90% of 
the ribosomes in the RNC preparations carried the respective peptide chain. The RNCs for this 
project were prepared by our technical assistant Anna Bursy. 
5.14 Fluorescence measurements  
5.14.1 Fluorescence and FRET measurements 
All fluorescence measurements performed at equilibrium were done at 25oC in a 750 µl quartz 
cuvette coated with lipids dissolved in chloroform (1:1000 v/v dilution). The titrations were 
performed by sequential addition of titrant and incubation for 1 – 2 min before each the 
measurement. To monitor the fluorescence of MDCC, the dye was excited at 420 nm and the 
emission was measured at 460 nm, the width of the slits was adjusted so that the counts per 
seconds (CPS) would be around 100000. The data was fitted to the quadratic equation: 𝐹 =




, where F is the fluorescence change, F0 the 




initial fluorescence, Fmax the final fluorescence level, Pt the total protein concentration, Lt 
added titrant concentration and Kd is the dissociation constant of the complex of P and L. 
5.14.2 Fluorescence anisotropy measurements 
The equilibrium measurements of fluorescence anisotropy were performed using the standard 
conditions provided by the software FluorEssence. The slit width was adjusted so that the 
fluorescence would be around 100000 CPS. The experimental conditions were the same as for 
the fluorescence measurements. The data was analyzed by fitting to the quadratic equation 
(explained above). 
5.15 Rapid kinetics (Stopped-flow)  
Stopped-flow measurements were performed in a stopped-flow apparatus SX-20 MV. Equal 
volumes (~ 55 µl) from the sample syringes were rapidly mixed in 10 mm path length cell and 
the change of fluorescent signal was recorded. This allowed monitoring of reaction kinetics in 
the time scale from 3 msec to several minutes. The fluorescence donor MDCC was excited at 
420 nm and the acceptor (BodipyFL or Alexa488) emission was measured after passing cut-off 
filter KV530. The reactions between SecYEG(ND) and FtsY, SecYEG(ND) and the ribosome 
were carried out at pseudo-first order conditions in BufferA at 250C. In general, five to six 
traces were averaged and evaluated by fitting to exponential function,  𝐹 = 𝐹∞ + 𝐴 ∗ 𝑒
−𝑘𝑎𝑝𝑝∗𝑡 
, with time constant (kapp), the amplitude of the signal change (A), the final signal (F∞) and 
fluorescence signal at time t(F). If necessary, additional exponential terms were included.  
5.16 GTP hydrolysis 
GTP hydrolysis was measured in multiple turnover conditions with excess of substrate over 
enzyme. The experiments were performed at 250C in BufferA. The reactions were initiated by 
adding of GTP doped with [γ32P]-GTP. Aliquots were taken at specific time points and the 
reaction was stopped by the addiing 50 % formic acid. At such acidic conditions spontaneous 
hydrolysis of GTP is unlikely to occur (Rodnina et al, 1999). To remove any precipitation the 
samples were centrifuged for 10 min at 13000 x g, at 40C and 1 µl of the supernatant was 
loaded on PEI 300 Polygram® plates. Inorganic phosphate and GTP were separated by thin 
layer chromatography for 20 min in 0.5M KH2PO4 pH 3.5 as mobile phase. The plates were 
developed on a FLA-7000 image reader and quantified using the densitometry software by 




MultiGauge. The amount of hydrolyzed GTP was calculated from the ration between the 
product, Pi and the total amount of GTP. The velocity of the reactions was measured the early 
stages of the reaction and the rates were calculated by fitting to a linear function, 𝐺𝑇𝑃ℎ𝑦𝑑𝑟. =
𝑎 + 𝑘𝑜𝑏𝑠 ∗ 𝑡 , with apparent rate constant (kobs), offset (a) and GTP hydrolyzed at time (t). The 
observed rates were plotted against the substrate concentration and fitted to a hyperbolic 
function,  𝑘𝑜𝑏𝑠 =  
𝐸∗𝑘𝑐𝑎𝑡∗𝑆
𝐾𝑚+𝑆
, with the total concentration of active sites (E), and the 
concentration of substrate (S) 
5.17 Buffers and Media 
Table 5-6 List of buffers and media 
Buffer Component  
Luria broth (LB) 
10 g/l NaCl, 10 g/l  tryptone, 5 g/l yeast extract; 
autoclave 20 min at 15 psi 
Luria broth agar 
10 g/l NaCl, 10 g/l tryptone, 5 g/l yeast extract, 15 
g/l agar; autoclave 20 min at 15 psi 
BufferA  
20 mM HEPES pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 
mM MgCl2, 10 % (w/v) glycerol 
Western blot Buffer A 
25 mM Tris-HCl pH 9.4, 40 mM 6-aminocarpoic 
acid, 20 % (v/v) methanol 
Western blot Buffer B 25 mM Tris-HCl pH 10.4, 20 % (v/v) methanol 
Western blot Buffer C 300 mM Tris-HCl pH 10.4 
10x PBS 
80 g/l NaCl, 2 g/l KCl, 14.4 g Na2PO4, 2.4 g/l 
KH2HPO4 
Native PAGE 10x cathode buffer 500 mM Tricine, 150 mM bis-Tris 
Native PAGE 10x anode buffer 500 mM bis-Tris-HCl pH7.0 
Clear native PAGE 2x sample buffer   
4 mM 6-aminocarpoic acid, 100 mM NaCl, 100 mM 
imidazole, 2 mM EDTA, 0.02 % (w/v) Ponceau, 20 % 
(w/v) glycerol 
4x Tris-Glycine SDS-PAGE stacking 
buffer 
0.5M Tris-HCl pH 6.8,  0.4 % (w/v)  SDS 
4 x Tris-Glycine SDS-PAGE separating 
buffer 
1.5 M Tris-HCl pH 8.8, 0.8 % (w/v) SDS  




5x SDS running buffer 125 mM  Tris, 960 mM glycine, 0.5 % (w/v)  SDS 
6x SDS loading buffer 
100 mM Tris-HCl pH 6.5, 20 mM BME, 6% SDS, 60% 
(w/v) glycerol, 0.2 % (w/v) bromphenol blue 
10x Gel-shift gel buffer 
500 mM Tris pH 6.5, 750 mM ammonium acetate, 10 
mM magnesium acetate 
1 x Gel-shift running buffer 
50 mM Tris pH 6.5, 75 mM ammonium acetate, 1 
mM EDTA, 1 mM DTT 
Colloidal Coomassie 
10 % (w/v) ammonium sulphate, 0.1 % (w/v) 
Coomassie G-250, 3 % (v/v) ortho-phosphoric acid, 
20 % (v/v) ethanol 
SecRB 20 mM HEPES pH 7.5, 200 mM NaCl, 5 mM MgCl2 
SecSB 
20 mM HEPES pH 7.5, 1 M NaCl, 5 mM MgCl2, 20 
mM imidazole pH 8.0, 10 % w/v glycerol, 1 % w/v 
DDM 
SecNiA 
20 mM HEPES pH 7.5, 200 M NaCl, 5 mM MgCl2, 20 
mM imidazole pH 8.0, 10 % w/v glycerol, 0.03 % w/v 
DDM 
SecNiB 
20 mM HEPES pH 7.5, 200 M NaCl, 5 mM MgCl2, 
200 mM imidazole pH 8.0, 10 % w/v glycerol, 0.03 % 
w/v DDM 
SecSPA 
50 mM HEPES pH 8.0, 50 mM NaCl, 1 mM DTT, 10 
% w/v glycerol, 0.03 % DDM 
SecSPB 
50 mM HEPES pH 8.0, 600 mM NaCl, 1 mM DTT 
10 % w/v glycerol, 0.03 % DDM 
Labeling buffer  
20 mM HEPES pH 7.0, 150 mM KCl, 10 % w/v 
glycerol 
FY-QSA 
20 mM HEPES pH 7.5, 150 mM KCl, 2 mM EDTA pH 
8.0, 2 mM DTT, 0.01 % v/v Nikkol 
FY-QSB 
20 mM HEPES pH 7.5, 500 mM KCl, 2 mM EDTA pH 
8.0, 2 mM DTT, 0.01 % v/v Nikkol 
FY-NiA 
20 mM HEPES pH 7.5, 150 mM KCl, 10 % w/v 
glycerol 
FY-NiB 
20 mM HEPES pH 7.5, 1000 mM KCl, 10 mM 
imidazole pH 8.0, 10 % w/v glycerol 





20 mM HEPES pH 7.5, 150 mM KCl, 200 mM 
imidazole pH 8.0, 10 % w/v glycerol 
FY-QTA 
20 mM HEPES pH 7.5, 150 mM KCl + 10 % w/v 
glycerol 
FY-QTB 
20 mM HEPES pH 7.5, 500 mM KCl + 10 % w/v 
glycerol 
Ffh-NiA 
20 mM HEPES pH 7.5, 60 mM NH4Cl, 150 mM KCl, 
7 mM MgCl2, 20 mM imidazole pH 8.0 
Ffh-NiB 
20 mM HEPES pH 7.5, 60 mM NH4Cl, 500 mM KCl, 
7 mM MgCl2, 20 mM imidazole pH 8.0 
Ffh-NiC 
20 mM HEPES pH 7.5, 60 mM NH4Cl, 500 mM KCl, 
7 mM MgCl2, 250 mM imidazole pH 8.0 
Ffh-SPA 
20 mM HEPES pH 7.5, 60 mM NH4Cl, 50 mM KCl, 7 
mM MgCl2 + 10 % glycerol + 10 mM BME 
Ffh-SPB 
20 mM HEPES pH 7.5, 60 mM NH4Cl, 1.0 M KCl, 7 
mM MgCl2 + 10 % glycerol + 10 mM BME 
MSP-B1 
20 mM Tris pH 7.5, 1 % v/v Triton X-100, 0.01 % v/v 
Nikkol  
MSP-B2 
10 mM Tris pH 8.0, 500 mM NaCl, 1 % v/v Triton X, 
10 % w/v glycerol 
MSP-B3 
10 mM Tris pH 8.0, 500 mM NaCl, 50 mM Na-
cholate, 10 % w/v glycerol 
MSP-B4 10 mM Tris pH 8.0, 500 mM NaCl, 10 % w/v glycerol 
MSP-B5 
10 mM Tris pH 8.0, 500 mM NaCl, 200 mM 
imidazole pH 8.0, 10 % w/v glycerol 
5x transcription buffer 
200mM Tris pH 7.5, 75 mM MgCl2, 10 mM 
Spermidin, 50 mM NaCl 
RNA-BA 
30 mM bis-Tris – Hcl pH 6.0, 1 mM EDTA, 300 mM 
KCl 
RNA-BB 
30 mM bis-Tris – HCl pH 6.0, 1 mM EDTA, 1.5 M 
KCl 
10x TBE 
107.8 g/L Tris-base, 55.03 g/L boric acid, 40 ml 0.5 M 
EDTA pH 8.0 
RNA formamide loading dye 80% v/v formamide, 1x TBE, 0.1 % w/v Bromphenol 




blue, 0.1 % w/v Xylencyanol FF 
UREA PAGE 1x TBE, 12% v/v Acrylamide (19:1), 8 M Urea 
Methylene blue staining 80 mM NaOAc pH 5.0, 0.016 % w/v Methylene blue 
50x TAE buffer 
242 g/L Tris-base, 57.1 ml/L glacial acetic acid, 100 
ml/L 0.5 M EDTA pH 8.0 
6x DNA loading dye 
0.25 % w/v Bromphenol blue, 0.25 % w/v xylene 









Akopian D, Dalal K, Shen K, Duong F, Shan SO (2013a) SecYEG activates GTPases to drive the 
completion of cotranslational protein targeting. J Cell Biol 200: 397-405 
 
Akopian D, Shen K, Zhang X, Shan SO (2013b) Signal recognition particle: an essential protein-
targeting machine. Annu Rev Biochem 82: 693-721 
 
Alami M, Dalal K, Lelj-Garolla B, Sligar SG, Duong F (2007) Nanodiscs unravel the interaction 
between the SecYEG channel and its cytosolic partner SecA. EMBO J 26: 1995-2004 
 
Angelini S, Boy D, Schiltz E, Koch HG (2006) Membrane binding of the bacterial signal 
recognition particle receptor involves two distinct binding sites. J Cell Biol 174: 715-724 
 
Angelini S, Deitermann S, Koch HG (2005) FtsY, the bacterial signal-recognition particle 
receptor, interacts functionally and physically with the SecYEG translocon. EMBO Rep 6: 476-
481 
 
Ariosa AR, Duncan SS, Saraogi I, Lu X, Brown A, Phillips GJ, Shan SO (2013) Fingerloop 
activates cargo delivery and unloading during cotranslational protein targeting. Mol Biol Cell 
24: 63-73 
 
Ataide SF, Schmitz N, Shen K, Ke A, Shan SO, Doudna JA, Ban N (2011) The crystal structure 
of the signal recognition particle in complex with its receptor. Science 331: 881-886 
 
Bahari L, Parlitz R, Eitan A, Stjepanovic G, Bochkareva ES, Sinning I, Bibi E (2007) Membrane 
targeting of ribosomes and their release require distinct and separable functions of FtsY. J Biol 
Chem 282: 32168-32175 
 
Bassford P, Beckwith J (1979) Escherichia coli mutants accumulating the precursor of a 
secreted protein in the cytoplasm. Nature 277: 538-541 
 
Batey RT, Rambo RP, Lucast L, Rha B, Doudna JA (2000) Crystal structure of the 
ribonucleoprotein core of the signal recognition particle. Science 287: 1232-1239 
 
Batey RT, Sagar MB, Doudna JA (2001) Structural and energetic analysis of RNA recognition 






Beck K, Eisner G, Trescher D, Dalbey RE, Brunner J, Muller M (2001) YidC, an assembly site for 
polytopic Escherichia coli membrane proteins located in immediate proximity to the SecYE 
translocon and lipids. EMBO Rep 2: 709-714 
 
Becker T, Bhushan S, Jarasch A, Armache JP, Funes S, Jossinet F, Gumbart J, Mielke T, 
Berninghausen O, Schulten K, Westhof E, Gilmore R, Mandon EC, Beckmann R (2009) 
Structure of monomeric yeast and mammalian Sec61 complexes interacting with the 
translating ribosome. Science 326: 1369-1373 
 
Beckmann R, Bubeck D, Grassucci R, Penczek P, Verschoor A, Blobel G, Frank J (1997) 
Alignment of conduits for the nascent polypeptide chain in the ribosome-Sec61 complex. 
Science 278: 2123-2126 
 
Beckwith J (2013) The Sec-dependent pathway. Res Microbiol 164: 497-504 
 
Behrens C, Hartmann E, Kalies KU (2013) Single rRNA helices bind independently to the 
protein-conducting channel SecYEG. Traffic 14: 274-281 
 
Berks BC, Sargent F, Palmer T (2000) The Tat protein export pathway. Mol Microbiol 35: 260-
274 
 
Bernstein HD, Poritz MA, Strub K, Hoben PJ, Brenner S, Walter P (1989) Model for signal 
sequence recognition from amino-acid sequence of 54K subunit of signal recognition particle. 
Nature 340: 482-486 
 
Bernstein HD, Zopf D, Freymann DM, Walter P (1993) Functional substitution of the signal 
recognition particle 54-kDa subunit by its Escherichia coli homolog. Proc Natl Acad Sci U S A 
90: 5229-5233 
 
Bessonneau P, Besson V, Collinson I, Duong F (2002) The SecYEG preprotein translocation 
channel is a conformationally dynamic and dimeric structure. EMBO J 21: 995-1003 
 
Blobel G, Dobberstein B (1975) Transfer of proteins across membranes. I. Presence of 
proteolytically processed and unprocessed nascent immunoglobulin light chains on 
membrane-bound ribosomes of murine myeloma. J Cell Biol 67: 835-851 
 
Bonardi F, London G, Nouwen N, Feringa BL, Driessen AJ (2010) Light-induced control of 






Bornemann T, Joeckel J, Rodnina MV, Wintermeyer W (2008) Signal sequence-independent 
membrane targeting of ribosomes containing short nascent peptides within the exit tunnel. 
Nat Struct Mol Biol 15: 494-499 
 
Boy D, Koch HG (2009) Visualization of distinct entities of the SecYEG translocon during 
translocation and integration of bacterial proteins. Mol Biol Cell 20: 1804-1815 
 
Braig D, Bar C, Thumfart JO, Koch HG (2009) Two cooperating helices constitute the lipid-
binding domain of the bacterial SRP receptor. J Mol Biol 390: 401-413 
 
Breyton C, Haase W, Rapoport TA, Kuhlbrandt W, Collinson I (2002) Three-dimensional 
structure of the bacterial protein-translocation complex SecYEG. Nature 418: 662-665 
 
Brown S, Fournier MJ (1984) The 4.5 S RNA gene of Escherichia coli is essential for cell growth. 
J Mol Biol 178: 533-550 
 
Buskiewicz I, Kubarenko A, Peske F, Rodnina MV, Wintermeyer W (2005) Domain 
rearrangement of SRP protein Ffh upon binding 4.5S RNA and the SRP receptor FtsY. RNA 11: 
947-957 
 
Cannon KS, Or E, Clemons WM, Jr., Shibata Y, Rapoport TA (2005) Disulfide bridge formation 
between SecY and a translocating polypeptide localizes the translocation pore to the center of 
SecY. J Cell Biol 169: 219-225 
 
Cheng Z, Jiang Y, Mandon EC, Gilmore R (2005) Identification of cytoplasmic residues of 
Sec61p involved in ribosome binding and cotranslational translocation. J Cell Biol 168: 67-77 
 
Chiba K, Mori H, Ito K (2002) Roles of the C-terminal end of SecY in protein translocation and 
viability of Escherichia coli. J Bacteriol 184: 2243-2250 
 
Christopoulos A (2002) Allosteric binding sites on cell-surface receptors: novel targets for drug 
discovery. Nat Rev Drug Discov 1: 198-210 
 
Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized 
p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 
1367-1372 
 
Dalal K, Duong F (2010) Reconstitution of the SecY Translocon in Nanodiscs. In Protein 






Dalbey RE, Wang P, Kuhn A (2011) Assembly of bacterial inner membrane proteins. Annu Rev 
Biochem 80: 161-187 
 
de Gier JW, Luirink J (2001) Biogenesis of inner membrane proteins in Escherichia coli. Mol 
Microbiol 40: 314-322 
 
de Leeuw E, Poland D, Mol O, Sinning I, ten Hagen-Jongman CM, Oudega B, Luirink J (1997) 
Membrane association of FtsY, the E. coli SRP receptor. FEBS Lett 416: 225-229 
 
de Leeuw E, te Kaat K, Moser C, Menestrina G, Demel R, de Kruijff B, Oudega B, Luirink J, 
Sinning I (2000) Anionic phospholipids are involved in membrane association of FtsY and 
stimulate its GTPase activity. EMBO J 19: 531-541 
 
Denisov IG, Grinkova YV, Lazarides AA, Sligar SG (2004) Directed self-assembly of 
monodisperse phospholipid bilayer Nanodiscs with controlled size. J Am Chem Soc 126: 3477-
3487 
 
Deville K, Gold VA, Robson A, Whitehouse S, Sessions RB, Baldwin SA, Radford SE, Collinson I 
(2011) The oligomeric state and arrangement of the active bacterial translocon. J Biol Chem 
286: 4659-4669 
 
Drew D, Froderberg L, Baars L, de Gier JW (2003) Assembly and overexpression of membrane 
proteins in Escherichia coli. Biochim Biophys Acta 1610: 3-10 
 
Egea PF, Shan SO, Napetschnig J, Savage DF, Walter P, Stroud RM (2004) Substrate twinning 
activates the signal recognition particle and its receptor. Nature 427: 215-221 
 
Eitan A, Bibi E (2004) The core Escherichia coli signal recognition particle receptor contains 
only the N and G domains of FtsY. J Bacteriol 186: 2492-2494 
 
Flanagan JJ, Chen JC, Miao Y, Shao Y, Lin J, Bock PE, Johnson AE (2003) Signal recognition 
particle binds to ribosome-bound signal sequences with fluorescence-detected subnanomolar 
affinity that does not diminish as the nascent chain lengthens. J Biol Chem 278: 18628-18637 
 
Focia PJ, Shepotinovskaya IV, Seidler JA, Freymann DM (2004) Heterodimeric GTPase core of 






Frauenfeld J, Gumbart J, Sluis EO, Funes S, Gartmann M, Beatrix B, Mielke T, Berninghausen 
O, Becker T, Schulten K, Beckmann R (2011) Cryo-EM structure of the ribosome-SecYE 
complex in the membrane environment. Nat Struct Mol Biol 18: 614-621 
 
Funes S, Kauff F, van der Sluis EO, Ott M, Herrmann JM (2011) Evolution of YidC/Oxa1/Alb3 
insertases: three independent gene duplications followed by functional specialization in 
bacteria, mitochondria and chloroplasts. Biol Chem 392: 13-19 
 
Gogala M, Becker T, Beatrix B, Armache JP, Barrio-Garcia C, Berninghausen O, Beckmann R 
(2014) Structures of the Sec61 complex engaged in nascent peptide translocation or membrane 
insertion. Nature 506: 107-110 
 
Gu SQ, Peske F, Wieden HJ, Rodnina MV, Wintermeyer W (2003) The signal recognition 
particle binds to protein L23 at the peptide exit of the Escherichia coli ribosome. RNA 9: 566-
573 
 
Gumbart J, Chipot C, Schulten K (2011a) Free-energy cost for translocon-assisted insertion of 
membrane proteins. Proc Natl Acad Sci U S A 108: 3596-3601 
 
Gumbart J, Chipot C, Schulten K (2011b) Free energy of nascent-chain folding in the 
translocon. J Am Chem Soc 133: 7602-7607 
 
Gumbart JC, Teo I, Roux B, Schulten K (2013) Reconciling the roles of kinetic and 
thermodynamic factors in membrane-protein insertion. J Am Chem Soc 135: 2291-2297 
 
Hainzl T, Huang S, Merilainen G, Brannstrom K, Sauer-Eriksson AE (2011) Structural basis of 
signal-sequence recognition by the signal recognition particle. Nat Struct Mol Biol 18: 389-391 
 
Hainzl T, Huang S, Sauer-Eriksson AE (2007) Interaction of signal-recognition particle 54 
GTPase domain and signal-recognition particle RNA in the free signal-recognition particle. 
Proc Natl Acad Sci U S A 104: 14911-14916 
 
Halic M, Blau M, Becker T, Mielke T, Pool MR, Wild K, Sinning I, Beckmann R (2006a) 
Following the signal sequence from ribosomal tunnel exit to signal recognition particle. Nature 
444: 507-511 
 
Halic M, Gartmann M, Schlenker O, Mielke T, Pool MR, Sinning I, Beckmann R (2006b) Signal 







Hanada M, Nishiyama K, Tokuda H (1996) SecG plays a critical role in protein translocation in 
the absence of the proton motive force as well as at low temperature. FEBS Lett 381: 25-28 
 
Hanein D, Matlack KE, Jungnickel B, Plath K, Kalies KU, Miller KR, Rapoport TA, Akey CW 
(1996) Oligomeric rings of the Sec61p complex induced by ligands required for protein 
translocation. Cell 87: 721-732 
 
Hegde RS, Bernstein HD (2006) The surprising complexity of signal sequences. Trends Biochem 
Sci 31: 563-571 
 
Higy M, Gander S, Spiess M (2005) Probing the environment of signal-anchor sequences 
during topogenesis in the endoplasmic reticulum. Biochemistry 44: 2039-2047 
 
Holland IB (2010) The extraordinary diversity of bacterial protein secretion mechanisms. 
Methods Mol Biol 619: 1-20 
 
Holtkamp W, Lee S, Bornemann T, Senyushkina T, Rodnina MV, Wintermeyer W (2012a) 
Dynamic switch of the signal recognition particle from scanning to targeting. Nat Struct Mol 
Biol: doi: 10.1038/nsmb.2421 
 
Holtkamp W, Lee S, Bornemann T, Senyushkina T, Rodnina MV, Wintermeyer W (2012b) 
Dynamic switch of the signal recognition particle from scanning to targeting. Nat Struct Mol 
Biol 19: 1332-1337 
 
Hsu LM, Zagorski J, Fournier MJ (1984) Cloning and sequence analysis of the Escherichia coli 
4.5 S RNA gene. J Mol Biol 178: 509-531 
 
Ismail N, Hedman R, Schiller N, von Heijne G (2012) A biphasic pulling force acts on 
transmembrane helices during translocon-mediated membrane integration. Nat Struct Mol Biol 
19: 1018-1022 
 
Jagath JR, Matassova NB, de Leeuw E, Warnecke JM, Lentzen G, Rodnina MV, Luirink J, 
Wintermeyer W (2001) Important role of the tetraloop region of 4.5S RNA in SRP binding to its 
receptor FtsY. RNA 7: 293-301 
 
Jagath JR, Rodnina MV, Lentzen G, Wintermeyer W (1998) Interaction of guanine nucleotides 






Jagath JR, Rodnina MV, Wintermeyer W (2000) Conformational changes in the bacterial SRP 
receptor FtsY upon binding of guanine nucleotides and SRP. J Mol Biol 295: 745-753 
 
Janda CY, Li J, Oubridge C, Hernandez H, Robinson CV, Nagai K (2010) Recognition of a signal 
peptide by the signal recognition particle. Nature 465: 507-510 
 
Junne T, Kocik L, Spiess M (2010) The hydrophobic core of the Sec61 translocon defines the 
hydrophobicity threshold for membrane integration. Mol Biol Cell 21: 1662-1670 
 
Kedrov A, Kusters I, Krasnikov VV, Driessen AJ (2011) A single copy of SecYEG is sufficient for 
preprotein translocation. EMBO J 30: 4387-4397 
 
Keenan RJ, Freymann DM, Walter P, Stroud RM (1998) Crystal structure of the signal 
sequence binding subunit of the signal recognition particle. Cell 94: 181-191 
 
Kihara A, Akiyama Y, Ito K (1995) FtsH is required for proteolytic elimination of uncomplexed 
forms of SecY, an essential protein translocase subunit. Proc Natl Acad Sci U S A 92: 4532-4536 
 
Krieg UC, Walter P, Johnson AE (1986) Photocrosslinking of the signal sequence of nascent 
preprolactin to the 54-kilodalton polypeptide of the signal recognition particle. Proc Natl Acad 
Sci U S A 83: 8604-8608 
 
Kudva R, Denks K, Kuhn P, Vogt A, Muller M, Koch HG (2013) Protein translocation across the 
inner membrane of Gram-negative bacteria: the Sec and Tat dependent protein transport 
pathways. Res Microbiol 164: 505-534 
 
Kuhn P, Weiche B, Sturm L, Sommer E, Drepper F, Warscheid B, Sourjik V, Koch HG (2011) 
The bacterial SRP receptor, SecA and the ribosome use overlapping binding sites on the SecY 
translocon. Traffic 12: 563-578 
 
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 227: 680-685 
 
Lakowicz JR (2003) Principles of fluorescence spectroscopy, 3rd Edition: Springer. 
 
Lam VQ, Akopian D, Rome M, Henningsen D, Shan SO (2010) Lipid activation of the signal 







Leipe DD, Wolf YI, Koonin EV, Aravind L (2002) Classification and evolution of P-loop GTPases 
and related ATPases. J Mol Biol 317: 41-72 
 
Luirink J, ten Hagen-Jongman CM, van der Weijden CC, Oudega B, High S, Dobberstein B, 
Kusters R (1994) An alternative protein targeting pathway in Escherichia coli: studies on the 
role of FtsY. EMBO J 13: 2289-2296 
 
Lycklama ANJA, Driessen AJ (2012) The bacterial Sec-translocase: structure and mechanism. 
Philos Trans R Soc Lond B Biol Sci 367: 1016-1028 
 
Maillard AP, Lalani S, Silva F, Belin D, Duong F (2007) Deregulation of the SecYEG 
translocation channel upon removal of the plug domain. J Biol Chem 282: 1281-1287 
 
Martoglio B, Hofmann MW, Brunner J, Dobberstein B (1995) The protein-conducting channel 
in the membrane of the endoplasmic reticulum is open laterally toward the lipid bilayer. Cell 
81: 207-214 
 
Menetret JF, Schaletzky J, Clemons WM, Jr., Osborne AR, Skanland SS, Denison C, Gygi SP, 
Kirkpatrick DS, Park E, Ludtke SJ, Rapoport TA, Akey CW (2007) Ribosome binding of a single 
copy of the SecY complex: implications for protein translocation. Mol Cell 28: 1083-1092 
 
Millman JS, Andrews DW (1999) A site-specific, membrane-dependent cleavage event defines 
the membrane binding domain of FtsY. J Biol Chem 274: 33227-33234 
 
Millman JS, Qi HY, Vulcu F, Bernstein HD, Andrews DW (2001) FtsY binds to the Escherichia 
coli inner membrane via interactions with phosphatidylethanolamine and membrane proteins. 
J Biol Chem 276: 25982-25989 
 
Milstein C, Brownlee GG, Harrison TM, Mathews MB (1972) A possible precursor of 
immunoglobulin light chains. Nat New Biol 239: 117-120 
 
Mircheva M, Boy D, Weiche B, Hucke F, Graumann P, Koch HG (2009) Predominant 
membrane localization is an essential feature of the bacterial signal recognition particle 
receptor. BMC Biol 7: 76 
 
Mitra K, Schaffitzel C, Shaikh T, Tama F, Jenni S, Brooks CL, 3rd, Ban N, Frank J (2005) 







Mori H, Ito K (2006) Different modes of SecY-SecA interactions revealed by site-directed in 
vivo photo-cross-linking. Proc Natl Acad Sci U S A 103: 16159-16164 
 
Murphy CK, Beckwith J (1994) Residues essential for the function of SecE, a membrane 
component of the Escherichia coli secretion apparatus, are located in a conserved cytoplasmic 
region. Proc Natl Acad Sci U S A 91: 2557-2561 
 
Nagamori S, Smirnova IN, Kaback HR (2004) Role of YidC in folding of polytopic membrane 
proteins. J Cell Biol 165: 53-62 
 
Nishiyama K, Suzuki T, Tokuda H (1996) Inversion of the membrane topology of SecG coupled 
with SecA-dependent preprotein translocation. Cell 85: 71-81 
 
Papanikou E, Karamanou S, Economou A (2007) Bacterial protein secretion through the 
translocase nanomachine. Nat Rev Microbiol 5: 839-851 
 
Park E, Rapoport TA (2012) Mechanisms of Sec61/SecY-mediated protein translocation across 
membranes. Annu Rev Biophys 41: 21-40 
 
Parlitz R, Eitan A, Stjepanovic G, Bahari L, Bange G, Bibi E, Sinning I (2007) Escherichia coli 
signal recognition particle receptor FtsY contains an essential and autonomous membrane-
binding amphipathic helix. J Biol Chem 282: 32176-32184 
 
Peluso P, Shan SO, Nock S, Herschlag D, Walter P (2001) Role of SRP RNA in the GTPase 
cycles of Ffh and FtsY. Biochemistry 40: 15224-15233 
 
Pogliano JA, Beckwith J (1994) SecD and SecF facilitate protein export in Escherichia coli. 
EMBO J 13: 554-561 
 
Pollastri G, Przybylski D, Rost B, Baldi P (2002) Improving the prediction of protein secondary 
structure in three and eight classes using recurrent neural networks and profiles. Proteins 47: 
228-235 
 
Pool MR, Stumm J, Fulga TA, Sinning I, Dobberstein B (2002) Distinct modes of signal 
recognition particle interaction with the ribosome. Science 297: 1345-1348 
 
Powers T, Walter P (1997) Co-translational protein targeting catalyzed by the Escherichia coli 






Prinz A, Behrens C, Rapoport TA, Hartmann E, Kalies KU (2000) Evolutionarily conserved 
binding of ribosomes to the translocation channel via the large ribosomal RNA. EMBO J 19: 
1900-1906 
 
Pugsley AP (1993) The complete general secretory pathway in gram-negative bacteria. 
Microbiol Rev 57: 50-108 
 
Raden D, Song W, Gilmore R (2000) Role of the cytoplasmic segments of Sec61alpha in the 
ribosome-binding and translocation-promoting activities of the Sec61 complex. J Cell Biol 150: 
53-64 
 
Reinau ME, Thogersen IB, Enghild JJ, Nielsen KL, Otzen DE (2010) The diversity of FtsY-lipid 
interactions. Biopolymers 93: 595-606 
 
Reyes CL, Rutenber E, Walter P, Stroud RM (2007) X-ray structures of the signal recognition 
particle receptor reveal targeting cycle intermediates. PLoS One 2: e607 
 
Rodnina MV, Savelsbergh A, Matassova NB, Katunin VI, Semenkov YP, Wintermeyer W (1999) 
Thiostrepton inhibits the turnover but not the GTPase of elongation factor G on the ribosome. 
Proc Natl Acad Sci U S A 96: 9586-9590 
 
Rodnina MV, Wintermeyer W (1995) GTP consumption of elongation factor Tu during 
translation of heteropolymeric mRNAs. Proc Natl Acad Sci U S A 92: 1945-1949 
 
Romisch K, Webb J, Herz J, Prehn S, Frank R, Vingron M, Dobberstein B (1989) Homology of 
54K protein of signal-recognition particle, docking protein and two E. coli proteins with 
putative GTP-binding domains. Nature 340: 478-482 
 
Rosendal KR, Wild K, Montoya G, Sinning I (2003) Crystal structure of the complete core of 
archaeal signal recognition particle and implications for interdomain communication. Proc 
Natl Acad Sci U S A 100: 14701-14706 
 
Runnels LW, Scarlata SF (1995) Theory and application of fluorescence homotransfer to 
melittin oligomerization. Biophys J 69: 1569-1583 
 
Sachelaru I, Petriman NA, Kudva R, Kuhn P, Welte T, Knapp B, Drepper F, Warscheid B, Koch 
HG (2013) YidC occupies the lateral gate of the SecYEG translocon and is sequentially 






Saparov SM, Erlandson K, Cannon K, Schaletzky J, Schulman S, Rapoport TA, Pohl P (2007) 
Determining the conductance of the SecY protein translocation channel for small molecules. 
Mol Cell 26: 501-509 
 
Satoh Y, Matsumoto G, Mori H, Ito K (2003) Nearest neighbor analysis of the SecYEG complex. 
1. Identification of a SecY-SecG interface. Biochemistry 42: 7434-7441 
 
Scheuring J, Braun N, Nothdurft L, Stumpf M, Veenendaal AK, Kol S, van der Does C, Driessen 
AJ, Weinkauf S (2005) The oligomeric distribution of SecYEG is altered by SecA and 
translocation ligands. J Mol Biol 354: 258-271 
 
Scotti PA, Urbanus ML, Brunner J, de Gier JW, von Heijne G, van der Does C, Driessen AJ, 
Oudega B, Luirink J (2000) YidC, the Escherichia coli homologue of mitochondrial Oxa1p, is a 
component of the Sec translocase. EMBO J 19: 542-549 
 
Segel IH (1993) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State 
Enzyme Systems: Wiley. 
 
Shen K, Arslan S, Akopian D, Ha T, Shan SO (2012) Activated GTPase movement on an RNA 
scaffold drives co-translational protein targeting. Nature 492: 271-275 
 
Shen K, Wang Y, Hwang Fu YH, Zhang Q, Feigon J, Shan SO (2013) Molecular mechanism of 
GTPase activation at the signal recognition particle (SRP) RNA distal end. J Biol Chem 288: 
36385-36397 
 
Shevchenko A, Wilm M, Vorm O, Jensen ON, Podtelejnikov AV, Neubauer G, Mortensen P, 
Mann M (1996) A strategy for identifying gel-separated proteins in sequence databases by MS 
alone. Biochem Soc Trans 24: 893-896 
 
Siekevitz P, Palade GE (1958) A cyto-chemical study on the pancreas of the guinea pig. III. In 
vivo incorporation of leucine-1-C14 into the proteins of cell fractions. J Biophys Biochem Cytol 
4: 557-566 
 
Smits AH, Jansen PW, Poser I, Hyman AA, Vermeulen M (2013) Stoichiometry of chromatin-
associated protein complexes revealed by label-free quantitative mass spectrometry-based 






Spanggord RJ, Siu F, Ke A, Doudna JA (2005) RNA-mediated interaction between the peptide-
binding and GTPase domains of the signal recognition particle. Nat Struct Mol Biol 12: 1116-
1122 
 
Stjepanovic G, Kapp K, Bange G, Graf C, Parlitz R, Wild K, Mayer MP, Sinning I (2011a) Lipids 
trigger a conformational switch that regulates signal recognition particle (SRP)-mediated 
protein targeting. J Biol Chem 286: 23489-23497 
 
Stjepanovic G, Kapp K, Bange G, Graf C, Parlitz R, Wild K, Mayer MP, Sinning I (2011b) Lipids 
trigger a conformational switch that regulates signal recognition particle (SRP)-mediated 
protein targeting. J Biol Chem 286: 23489-23497 
 
Tam PC, Maillard AP, Chan KK, Duong F (2005) Investigating the SecY plug movement at the 
SecYEG translocation channel. The EMBO journal 24: 3380-3388 
 
Traut TW (1994) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 
140: 1-22 
 
Tsukazaki T, Mori H, Echizen Y, Ishitani R, Fukai S, Tanaka T, Perederina A, Vassylyev DG, 
Kohno T, Maturana AD, Ito K, Nureki O (2011) Structure and function of a membrane 
component SecDF that enhances protein export. Nature 474: 235-238 
 
Valent QA, Scotti PA, High S, de Gier JW, von Heijne G, Lentzen G, Wintermeyer W, Oudega 
B, Luirink J (1998) The Escherichia coli SRP and SecB targeting pathways converge at the 
translocon. EMBO J 17: 2504-2512 
 
Van den Berg B, Clemons WM, Jr., Collinson I, Modis Y, Hartmann E, Harrison SC, Rapoport 
TA (2004) X-ray structure of a protein-conducting channel. Nature 427: 36-44 
 
van der Sluis EO, Driessen AJ (2006) Stepwise evolution of the Sec machinery in 
Proteobacteria. Trends Microbiol 14: 105-108 
 
Veenendaal AK, van der Does C, Driessen AJ (2001) Mapping the sites of interaction between 
SecY and SecE by cysteine scanning mutagenesis. J Biol Chem 276: 32559-32566 
 
Voigts-Hoffmann F, Schmitz N, Shen K, Shan SO, Ataide SF, Ban N (2013) The structural basis 






von Heijne G, Abrahmsen L (1989) Species-specific variation in signal peptide design. 
Implications for protein secretion in foreign hosts. FEBS Lett 244: 439-446 
 
von Loeffelholz O, Knoops K, Ariosa A, Zhang X, Karuppasamy M, Huard K, Schoehn G, 
Berger I, Shan SO, Schaffitzel C (2013) Structural basis of signal sequence surveillance and 
selection by the SRP-FtsY complex. Nat Struct Mol Biol 20: 604-610 
 
Wagner S, Klepsch MM, Schlegel S, Appel A, Draheim R, Tarry M, Hogbom M, van Wijk KJ, 
Slotboom DJ, Persson JO, de Gier JW (2008) Tuning Escherichia coli for membrane protein 
overexpression. Proc Natl Acad Sci U S A 105: 14371-14376 
 
Weber K, Pringle JR, Osborn M (1972) Measurement of molecular weights by electrophoresis 
on SDS-acrylamide gel. Methods Enzymol 26: 3-27 
 
Weiche B, Burk J, Angelini S, Schiltz E, Thumfart JO, Koch HG (2008) A cleavable N-terminal 
membrane anchor is involved in membrane binding of the Escherichia coli SRP receptor. J Mol 
Biol 377: 761-773 
 
White SH, von Heijne G (2008) How translocons select transmembrane helices. Annu Rev 
Biophys 37: 23-42 
 
Wu ZC, de Keyzer J, Kedrov A, Driessen AJ (2012) Competitive binding of the SecA ATPase 
and ribosomes to the SecYEG translocon. J Biol Chem 287: 7885-7895 
 
Zhang B, Miller TF, 3rd (2012) Long-timescale dynamics and regulation of Sec-facilitated 
protein translocation. Cell Rep 2: 927-937 
 
Zhang X, Kung S, Shan SO (2008) Demonstration of a multistep mechanism for assembly of 
the SRP x SRP receptor complex: implications for the catalytic role of SRP RNA. J Mol Biol 381: 
581-593 
 
Zimmer J, Nam Y, Rapoport TA (2008) Structure of a complex of the ATPase SecA and the 
protein-translocation channel. Nature 455: 936-943 
 
Zopf D, Bernstein HD, Johnson AE, Walter P (1990) The methionine-rich domain of the 54 kd 
protein subunit of the signal recognition particle contains an RNA binding site and can be 
crosslinked to a signal sequence. EMBO J 9: 4511-4517 
 






Zwieb C, van Nues RW, Rosenblad MA, Brown JD, Samuelsson T (2005) A nomenclature for all 











List of abbreviations 
Abbreviation  Description 
Alx488 Alexa Fluor 488 
APS Ammonium persulfate 
BME β-mercaptoethanol 
Bpy Bodipy FL 
CNP Clear native PAGE 
Cryo-EM Cryo electron microscopy 
CV Column volume 
DDM n-Dodecyl β-D-Maltopyranoside 
dNTP Deoxyribonucleotide triphosphate 
DTT Dithiothreitol  
e.g. exempli gratia, for example 
EM Electron microscopy 
ER Endoplasmic reticulum 
et al. et alii, and other 
FCS Fluorescence correlation spectroscopy 
FRET Fluorescence resonance energy transfer 
FtsY-A197 FtsY construct 1 – 197 amino acids 
FtsY-A208 FtsY construct 1 – 208 amino acids 
FtsY-NG FtsY construct 197 – 497 amino acids 
FtsY-NG+1 FtsY construct 196 – 497 amino acids 
GAP GTPase activation factor 
GDP Guanosine diphosphate 
GEF Guanine nucleotide exchange factor 
GFP Green fluorescent protein 
GMPPNP Non-hydrolyzable GTP analog 5'-Guanylyl imidodiphosphate 
GTP Guanosine triphosphate 
i.e. id est, that is 
iBAQ Intensity based absolute quantification 
INV Inner membrane vesicles 





kapp Apparent rate constant 
kcat Catalytic rate constant 
Kd Dissociation constant 
Km Michaelis-Menten constant 
LepB Leader peptidase 
MDCC 7-Diethylamino-3-((((2-Maleimidyl)ethyl)amino)carbonyl)coumarin 
MTS Membrane targeting sequence 
MW Molecular weight  
ND Nanodiscs 
Nikkol Nonaethylene glycol monododecyl ether 
PMF Proton-motive force 
QSY9 Fluorescence quencher 
RNC Ribosomal nascent chain complex 
SAS Signal anchor sequence 
SDS Soldiumdodecylsulfate 
SDS-PAGE Soldiumdodecylsulfate polyacrylamide gel electrophoresis 
SecYEG(ND) SecYEG embedded in nanodisc 
SPase Signal peptidase 
SPR Surface plasmon resonance 
SRP Signal recognition particle 
SS Signal sequence 
TEMED Tetramethylethylenediamine 







List of tables 
 
Table 2-1: Affinity of FtsY binding to SecYEG 25 
Table 2-2: Affinity of FtsY NG and A domains in binding to SecYEG(ND) 30 
Table 2-3 Free energies of the binding of SecYEG(ND) to FtsY and of the interaction between FtsY 
NG and A domains 31 
Table 2-4: Steady-state GTPase of FtsY, SRP, and FtsY/SRP 46 
Table 2-5 GTPase rate constants of the SRP complex with FtsY-NG domain variants in the 
presence of SecYEG(ND) and ND 47 
Table 4-1 List of equipment 57 
Table 4-2 List of software 58 
Table 4-3: List of plasmids 58 
Table 4-4: List of bacterial strains 59 
Table 4-5 List of primers 60 
Table 4-6 List of buffers and media 71 
 
List of figures 
 
Figure 1-1 Overview of the major protein targeting pathways in Gram-negative bacteria 4 
Figure 1-2 Structure of SecYEG 7 
Figure 1-3 Structure and connections of the nanodiscs embedded SecYE to the ribosome 9 
Figure 1-4 Structure of SRP and its contacts with the ribosome and the SAS 12 
Figure 1-5 The complex of SRP and FtsY 14 
Figure 1-6 Structure of FtsY 16 
Figure 2-1: SecYEG purification. 20 
Figure 2-2 Purification and analysis of nanodiscs containing SecYEG. 21 
Figure 2-3 Characterization of SecYEG(ND) by iBAQ negative-staining EM 22 
Figure 2-4 FtsY binding to SecYEG in different environments. 23 
Figure 2-5 Affinity of FtsY binding to SecYEG. 24 
Figure 2-6 FtsY binding to SecYEG(ND) in the presence of ND. 26 
Figure 2-7 Stability of the complex between SecYEG(ND) and FtsY. 27 
Figure 2-8 FtsY constructs. 29 
Figure 2-9 Binding of the FtsY-NG and the FtsY-A domain. 30 





Figure 2-11 FtsY domain rearrangements upon binding toSecYEG(ND) or ND monitored by 
homoFRET. 33 
Figure 2-12 Influence of FtsY-NG and A domains on FtsY binding to SecYEG(ND). 35 
Figure 2-13 Affinity of SecYEG(ND) binding to the ribosome. 37 
Figure 2-14 Rapid kinetics of SecYEG(ND) complex formation with the ribosomes. 38 
Figure 2-15 Dissociation kinetics of the complex of SecYEG(ND) with the ribosomes. 39 
Figure 2-16 Dissociation of FtsY from SecYEG(ND) in competition with vacant ribosomes 40 
Figure 2-17 Titration of SecY(111MDCC)EG(ND) with FtsY(196Bpy) in the presence of increasing 
amounts of ribosomes or RNCs. 42 
Figure 2-18 FtsY effect on ribosome-SecYEG(ND) complex formation. 43 
Figure 2-19 Intrinsic GTPase activity of FtsY. 45 
Figure 2-20 Titration of FtsY, SRP and the SRP-FtsY complex with GTP. 45 
Figure 2-21 GTPase activity of FtsY bound to SecYEG(ND) or ND 47 
Figure 2-22 GTPase activity of the SRP complex with FtsY or FtsY-NG domain variants in the 
presence of SecYEG(ND) or ND. 48 
Figure 3-1 Model of FtsY binding to SecYEG 52 








In the past four years I have walked a long way and a lot of people have contributed to it, I 
hope I will not forget anyone. 
I am very grateful to Marina Rodnina and Wolfgang Wintermeyer for taking me on board and 
giving me the opportunity to do my doctoral work with them. I would like especially to thank 
Wolfgang for teaching me about fluorescence and thermodynamics, for his ideas and for the 
help during writing this thesis. I would like ot thank Marina for all the discussions and 
advices. 
I would like to thank my thesis committee members Marina Bennati and Kai Tittmann for 
their advices and also my extended examination board members Holger Stark, Manfred 
Konrad and Peter Rehling. Likewise, I have really appreciated the GGNB program and the 
whole organizational team. 
I would also like to thank everyone at the Ribosome Dynamics group: Thomas Bornemann and 
Wolf Holtkamp for the day to day discussions, support and for the nice working atmosphere 
in the lab; Sejeong Lee and Yan Ge for the working side by side, for their friendship and 
showing me Asian culture and cuisine; Anna Bursy for making my PCR reactions work and 
making tones of RNCs; Franziska Hummel for always showing me that there is more than one 
way to do things. Nevertheless, Johannes Jöckel is no longer part of our group, I would like to 
thank him for the introduction to nanodiscs preparation and for providing us with the ITC 
data.  
Also many thanks to the postdocs at the Physical Biochemistry department, especially to: Pohl 
Milon for the help with the stopped-flow and sharing his experience on kinetics and protein 
labeling; Andrey Koneverga for the help with the HPLCs and all the discussions; Ingo 
Wohlgemuth for sharing his knowledge about GTPases and for idea to use iBAQ; Marcus 
Jäger for all the talks about FRET and fluorescence; I really learned a lot from all of you. I 
should not forget Michael Thommen, we are very grateful with Anna for the help with RNC 
preparation. My appreciation to the people who help me with the iBAQ – Illian Atanassov 
(and for always lifting my spirit), and negative staining EM – Andrius Krasauskas (and for the 





Also I would like to thank technical assistants of the department Manuela Beck-Corell, Anna 
Bursy, Olaf Geintzer, Franziska Hummel, Sandra Kapller, Christina Kothe, Theresia Uhlendorf, 
Antony Wiles, Tanja Wiles, Michael Zimmermann, for the excellent technical support. 
I would also like to thank everyone in the department for the great atmosphere; PhD/Postdocs 
get together organization. Speaking about organization I would like to thank our secretary 
Dimitra Papastavrou, for all the bureaucracy assistance. 
But it was not all the time only work, I also met great friends to go skiing, diving, travelling, 
playing volleyball, mushroom hunting thank you: Liu, Dima, Ka, Lena, Andrey, Sergey, Katya, 
Michi, Raffa, Riccardo, Inessa, Tales, Tanja (thank you for taking me pony petting). Also 
learning German was fun with Eve and Rebecca. Bulgarian lunches were great with Plamen, 
Anastassia, Miro, Irena, Ivan. Andreea, it was a pleasure to be student representative with you, 
to organize the retreat and to have so many cocktails. My dear friend Miro (Mirsha), thank 
you so much for patience and support, all your solid logic... And Michi thank you for being 
there, for the road trip and for trying to teach me to snowboard.  
Last but least I would like to give my deepest gratitude to my family and parents (Eli and Joro) 







Curriculumn vitae  
 
Albena Georgieva Draycheva 
Born: 20 Jan 1985, Sofia, Bulgaria 
Nationality: Bulgarian 
Education: 
Georg-August University, Göttingen, Germany April 2010 – Sept 2014 
Graduate studies at Göttingen Graduate School for Neurosciences, Biophysics, and Molecular 
Biosciences (GGNB) 
Free University, Berlin, Germany   Oct 2008 – March 2010 
Graduate studies at Berlin-Brandenburg School of Regenerative Therapies (BSRT) 
Uppsala University, Uppsala, Sweden    Jan 2007 – Aug 2008  
Master studies in biology 
Sofia University, Sofia, Bulgaria    Nov 2003 – July 2007 
Bachelor studies in molecular biology 
29 SOU Kuzman Shapkarev, Sofia, Bulgaria  Sept 1998 – June 2003 
High school education in humanitarian studies – major subjects: literature and history 
151 SOUPI, Sofia, Bulgaria   Sept 1991 – June 1998 
Primary school education 
Further information at:  
LinkedIn page http://www.linkedin.com/pub/albena-draycheva/2/250/948 
ResearchGate page https://www.researchgate.net/profile/Albena_Draycheva/  
